Update on newly diagnosed HIV infections. by Long, Jean
The Minister for Health and Children established the Strategic Task Force on
Alcohol in January 2002 as recommended by the First Report of the
Commission on Liquor Licensing. The brief of the Task Force is ‘to recommend
specific, evidence based measures to Government to prevent and reduce
alcohol related harm.’ The Task Force published an Interim Report in May
20021 which contained recommendations to: 
■ regulate availability 
■ reduce drink driving 
■ limit harm in drinking environments 
■ protect children and reduce
pressure on adolescents to drink 
■ provide information, education and
services 
■ develop key indicators to monitor
the situation 
Up to September 2004, progress has
been made in a number of key areas:2
■ Excise duty on cider and spirits was
increased; further increases on a
regular basis are intended.
■ The Intoxicating Liquor Act 2003 was published and contained measures to
deal with underage drinking as well as drunk and disorderly conduct. 
■ Bar staff have commenced training on responsible serving practices.
■ The writing of draft legislation to reduce the exposure of children to alcohol
marketing was commenced.
■ The Road Traffic Act was revised to permit more extensive breath testing for
drivers.
■ The drinks industry has established a process for reviewing proposed
advertising of alcohol products.
■ The Irish Sports Council published the Code of Ethics and Good Practice for
Children’s Sport in Ireland in 2000, in line with the government’s guidelines
on child protection. 
■ A public awareness campaign (known as ‘Less is More’) has effectively
raised awareness among the general public about the harms associated
with excessive alcohol consumption.
■ There is mandatory education on the misuse of alcohol in both the primary
and secondary school curricula. 
■ A number of research studies have been completed, including the second
national lifestyles survey, a study investigating public attitudes to alcohol
policy changes, and a pilot project on identifying problem alcohol use in
general practice.
On 22 September 2004, the Task Force presented its Second Report to the
Minister for Health and Children.2 This report reviews current trends in alcohol
consumption and alcohol-related harm:
contents
Welcome to Issue 12 of Drugnet Ireland, the newsletter
of the Drug Misuse Research Division of the Health
Research Board. The role of this publication is to
disseminate information, news and research findings
among those involved in the drugs area in Ireland.
Tackling alcohol-related 
harm in Ireland
Drug Misuse Research Division
Health Research Board
Holbrook House, Holles Street,
Dublin 2, Ireland 
t 01 6761176 
f 01 6618567 
e dmrd@hrb.ie 
w www.hrb.ie
drugnet Ireland 
Issue 12, November 2004Newsletter of the Drug Misuse Research Division
page 1 Tackling alcohol-related harm in Ireland
page 3 Garda study shows decline in drug-
related crime
page 5 In brief
page 6 Cannabis use by young people in Ireland
page 7 Consequences of cannabis use
page 9 Drug situation, consequences and
treatment in Irish prisons
page 11 Service providers’ views on harm
reduction services
page 13 Outcomes and experiences of
methadone maintenance
page 14 Drugs and driving
page 15 Irish EU Presidency and the drugs issue
page 16 Government Progress Report 2004: the
drugs issue
page 17 Sport and arts should be part of youth
substance abuse prevention strategy
page 18 Inter-agency protocols – a model of good
practice for agencies working with current
and former drug users in Blanchardstown
page 19 Community-based substance misuse
prevention courses in primary schools: 
a study 
page 21 The EDDRA column
page 22 Updated analysis from the National Drug
Treatment Reporting System
page 24 Update on newly diagnosed HIV
infections 
page 25 National Documentation Centre on Drug
Use
page 26 From Drugnet Europe
page 27 Addiction Research Centre Annual
Conference
page 28 Recent publications
page 31 Upcoming events
Dr Jim Kiely, Chair of the Strategic Task
Force on Alcohol, and the then Minister
for Health and Children, Mr Micheál
Martin TD, at the launch of the report
(Photo: Mac Innes Photography)
Tackling alcohol-related harm in Ireland (continued)
drugnet Ireland
Current trends in alcohol
consumption in Ireland 
◆ Ireland has the second highest per capita
consumption in the European Union.
◆ Alcohol consumption per person over 15 years
was 13.8 litres in 2003, a fall of 0.6 per cent
compared with 2001/2.
◆ Beer is the most common product consumed.
◆ Binge drinking is more common in Ireland than
in many other countries. Of every 100 drinking
sessions, 58 end in binge drinking for men and
38 end in binge drinking for women. 
◆ The HBSC 2002 study reported that at least half
of boys and girls between 15 and 17 years were
drinking at the time of the survey.
◆ Between 1993 and 2002, there was a dramatic
increase in the number of off-licences. 
◆ On average, alcohol expenditure represents 5.5
per cent of the total household expenditure. 
Recent trends in alcohol-related harm
◆ Between 1992 and 2002, alcohol-related
mortality rates increased for: cancers related to
alcohol; alcohol dependency; alcohol abuse and
psychosis; chronic liver disease and cirrhosis;
alcohol poisoning; and suicide.
◆ There is little trend data on health service
demand for treatment as a result of alcohol use,
apart from the following information: 
- A recent study reported that a large
proportion of the young people in North
Dublin who required treatment in an
accident and emergency at the weekend
did so a result of excessive drinking.
- A new study published in Addiction3
reported an 80 per cent increase in alcohol-
related emergency admissions at acute
hospitals in the North Eastern Health Board,
from 432 in 1997 to 777 in 2001. 
- In two health board areas, over 60 per cent
of those treated for problem substance use
reported that alcohol was their main
problem drug, and polydrug use was
reported by one-fifth of alcohol cases.
- Alcohol is a factor in two-fifths of parasuicides.
- In Ireland, as in other countries, there was a
positive association between per capital
alcohol consumption and population suicide
rates from 1999 to 2000.
- Figures from the Sexual Assualt Treatment
Unit reveal a fourfold increase in recent
years in the number of women requesting
tests to ascertain whether they has been
assaulted. Many of these women reported
that they believed their drink had been
spiked; however, toxicology only ever
detected large quantities of alcohol, rather
than other drugs.4
- 85 per cent of women continue drinking
during their pregnancy.
◆ Despite the introduction of penalty points, the
number of people killed on the roads between
9.00 pm and 4.00 am (which is a proxy for
alcohol-related deaths among road users) has
remained relatively stable.
The Second Report of the Strategic Task Force on
Alcohol has revised and expanded the
recommendations in the Interim Report to include
the following actions: 
■ Regulate availability by continuing to increase
excise duty, restricting the numbers of outlets,
restricting children’s access to places where
alcohol is served, and self-monitoring within the
community.
■ Control the promotion of alcohol through
legislation to restrict advertising, sponsorship
and sales promotions.
■ Enhance society’s capacity to respond to
alcohol-related harm through community
mobilisation, consultation with young people,
providing alcohol-free alternatives and
instituting professional training.
■ Protect public, private and working
environments through supporting parents and
encouraging good practices in the workplace.
■ The alcohol beverage industry will institute
responsible serving in both licensed and off-
licence outlets, ensure responsible labelling and
promote low- rather than high-alcohol beverages.
■ Continue to provide information and education
through public awareness, education in schools
and special programmes in community settings.
■ Develop effective treatment services through
early identification of problem alcohol use
(through primary care, emergency health
facilities and the justice system), and provision
of specialist treatment (referral pathways and
counselling).
■ Maximise support from non-government
organisations so that they can advocate for
policy change and create public awareness on
the harmful effects of alcohol.
■ Research and monitor progress through an
independent research and monitoring unit,
utilising all sources of information and
reviewing progress on key indicators.
■ Implement the drink-driving recommendations
presented in the 2002 report. 
(Jean Long)
1. Strategic Task Force on Alcohol (2002) Interim Report.
Dublin: Department of Health and Children.
2. Strategic Task Force on Alcohol (2004) Second Report.
Dublin: Department of Health and Children.
3. O’Farrell A, Allwright S, Downey J, Bedford D, Howell F
(2004) The burden of alcohol misuse on emergency in-
patient hospital admissions among residents from a health
board region in Ireland. Addiction, 99, 1279–1285. 
4. O’Farrell A (2004) Ireland and its drink problem: the
immediate adverse effects of binge drinking in Ireland.
Irish Medical Journal, 97 (6), 165-166.
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A recent study by the Garda Síochána Research
Unit (Furey and Browne 2004) has sought to
establish the link between opiate use and
criminal activity in Ireland for the years
2000/2001.1 An earlier study by Keogh (1997)
focused on the drug-crime relationship in Dublin
in 1996.2
Both studies combined the use of official police
statistics and interviews with drug users. The
purpose of the Keogh study was to provide
reliable information on the relationship between
illicit drugs and the commission of crime in the
Dublin Metropolitan Area (DMA). The study by
Furey and Browne extended the analysis to the
other Garda Síochána regions throughout the
state. Another difference between the two
studies is that Furey and Browne examined the
use of opiate-based drugs only, while Keogh
included some individuals who used only non-
opiates such as ecstasy, cocaine and
amphetamines. However, the majority (93%) of
the subjects in Keogh’s report were opiate users. 
The two studies incorporated three principal
phases. Phase One involved an estimation of the
total number of opiate users known to the
Gardaí at the time of the study. In the Keogh
study 3,817 opiate users were identified in the
DMA in 1996, while Furey and Browne recorded
a figure of 4,706 opiate users in the DMA.
However, a valid comparison cannot be made
between these figures. Firstly, Furey and
Browne’s figure is based on data for two years,
2000 and 2001, while Keogh’s figure is based on
data for a single year. Secondly, as Furey and
Browne point out, the DMA is now larger than it
was at the time of the Keogh study,
incorporating an extra garda division.
Phase Two involved a survey of a sample of the
drug users identified in phase one. The surveys
sought to elicit data about the drug users
themselves, their drug-taking environment and
their criminality. 
Phase Three involved an examination of national
crime figures in order to estimate the
relationship between opiate use and crime.
Keogh estimated that drug users were
responsible for 66 per cent of detected
indictable crime, while Furey and Browne
concluded that drug users were responsible for
just 28 per cent of detected crime. While this
difference is quite striking, it can be partly
explained by some of the survey findings from
Phase Two. A number of these findings are given
in Table 1.
In the Keogh study 59 per cent cited crime as
their main source of income, while the figure in
the Furey and Browne study was 13 per cent. It
is also noteworthy that the Keogh study
reported an unemployment rate of 84 per cent
among the sample, while Furey and Browne
reported an unemployment rate of 55 per cent.
This latter finding supports the economic
motivation theory by suggesting a lesser
dependence on the proceeds of crime in a
context of available employment. It also
indicates an ability among opiate users to
maintain employment despite their addiction. A
factor that may have contributed to this is the
increased availability of drug treatment in the
time between the two studies. Indeed, Furey
and Browne found that 75 per cent of
Garda study shows decline in 
drug-related crime
Table 1
Variable Keogh survey Furey and Browne 
1997 survey 2002
Crime as main source of income 59% 13%
Unemployment rate among drug users 84% 55%
Most common age of first taking drugs 15 years 15 years
Drug first used – cannabis 51% 55%
Drug first used – heroin 32 % 27%
First introduced to drugs by friend 81% 86%
Estimated daily expenditure on drugs* €51 €75
Percentage who sourced drugs from local drug dealer 46% 76%
Crime came before drugs 51% 33%
Drugs came before crime 30% 56%
Drug use and crime started together 19% 11%
Percentage who had been in prison 81% 66%
* Keogh estimated that the cost of one gram of heroin in 1997 was €100 (Keogh, 1997: 40). Furey and Browne do not
provide a figure. However, the current cost of one gram of heroin is approximately €190.
Keogh estimated
that drug users
were responsible
for 66 per cent
of detected
indictable crime,
while Furey and
Browne
concluded that
drug users were
responsible for
just 28 per cent
of detected
crimes.
respondents claimed that their receipt of drug
treatment had in fact decreased their criminal
activity.
A worrying finding of the Furey and Browne
study relates to the apparent stabilisation of
local drug markets over time and the ease of
drug availability. The study records an increase
from 46 to 76 per cent in the number stating
that they sourced their drugs from a local dealer.
This has important implications for local policing
and other supply control initiatives.
Another difference between the two studies
relates to the relationship between respondents’
initiation into drug use and their criminal
activity. While the Keogh study found that 51
per cent of respondents had committed crime
before beginning to use drugs, a finding which
is broadly consistent with the international
literature, Furey and Browne recorded a figure of
33 per cent.
The survey findings of the Furey and Browne
study must be treated with a degree of caution,
however, because of the poor survey response
rate. The response rate in the Furey and Browne
survey was just 27 per cent (131 out of 486)
compared to 78 per cent (351 out of 450) in the
Keogh study. Furey and Browne compared the
respondents and non-respondents in their survey
according to two available variables, gender and
possession of a criminal record, and found little
difference between the two groups. This provides
some evidence to suggest that the sample might
not be totally unrepresentative of the total
number of drug users known to the police. Furey
and Browne highlight the difficulties they
encountered in contacting potential respondents
and point to a 123 per cent increase in
homelessness between 1996 and 2002.
The difficulties encountered in accessing
respondents for interview in this study show the
obvious limitations of studies of this nature,
where the police seek information about
criminal behaviour from subjects they have
arrested or known. This relates to a possible
perception among respondents that by self-
reporting criminal behaviour they risk exposing
themselves to possible incrimination. Keogh, for
example, encountered difficulties in acquiring
specific information from respondents,
particularly concerning their participation in
violent criminal behaviour. Furey and Browne
suggest that a possible reason for the reluctance
among drug users to participate in their survey
may have been related to a perceived
deterioration in relations between the Gardaí
and drug users since 1997, which, the authors
contend, may have occurred as a consequence
of a number of policing operations targeted at
drug users.
Another methodological issue relates to the use
of Garda-recorded crime statistics. In order to
assist them in identifying known drug users and
to establish the relationship between opiate use
and crime, the two studies relied on different
data sources. Keogh relied on manual data and
an earlier Garda computer system while Furey
and Browne utilised the new Garda Síochána
PULSE system. The recent minority report of the
Expert Group on Crime Statistics has highlighted
major concerns in relation to the operation of
this data system and also about earlier crime-
recording practices.3
Despite these shortcomings, the Furey and
Browne study provides useful and recent
information about a hard-to-reach population.
(Johnny Connolly)
1. Furey M and Browne C (2004) Opiate use and related
criminal activity in Ireland 2000 and 2001. Dublin:
Garda Síochána Research Unit.
2. Keogh E (1997) Illicit drug use & related criminal activity
in the Dublin Metropolitan Area. Dublin: An Garda
Síochána.
3. Expert Group on Crime Statistics (2004) Minority
report. Dublin: Department of Justice, Equality and Law
Reform.
Garda study shows decline in drug-related crime (continued)
drugnet Ireland
4
drugnet Ireland
5
On 25 June the World Drug Report 2004 was
released by the UN Office on Drugs and Crime
(UNODC). It was released to coincide with
International Day against Drug Abuse and Illicit
Drug Trafficking (26 June). The first volume covers
market trends and provides in-depth trend analysis,
and the second volume compiles detailed statistics
on drug markets. 
www.unodc.org
On 26 June a year-long campaign ‘Drugs:
Treatment Works’ was launched by the UN
Office on Drugs and Crime (UNODC). It hopes to
diminish the stigma attached to drug users by
challenging the common misconception that ‘once
a drug abuser, always a drug abuser’. Campaign
materials are available on the UNODC website.
www.unodc.org
In June a Report on Alcohol Misuse by Young
People was released by the Joint Oireachtas
Committee on Health and Children. Among its 10
key recommendations, the Committee
recommended a complete ban on all alcohol
advertising within a three-year period, and a
complete ban on all acknowledgement or credit for
sponsorship of sports events, clubs or teams that
cater for members under 25 years of age, by any
area of the alcoholic drinks industry. 
In June MEAS (Mature Enjoyment of Alcohol
in Society Ltd) released ‘Underage Drinking is
Rarely Black and White’. The research found that
half the country’s 16- and 17-year-olds are drinking
alcohol ‘regularly’ and that domestic (at home)
drinking by parents is a key influencer of their
children. MEAS intends to use the research findings
to inform the content and direction of its work in
seeking solutions.
www.meas.ie 
In June the Safety, Health and Welfare at
Work Bill 2004 was published. The Bill requires
an employee, at work, to ensure that he or she is
not under the influence of an intoxicant [alcohol or
drug, and any combination of drugs or of drugs
and alcohol] to the extent that he or she endangers
his or her own safety, health or welfare at work or
that of any other person. It also requires an
employee, if reasonably required by his or her
employer, to submit to any appropriate, reasonable
and proportionate tests by a competent person.
www.oireachtas.ie
In June the Dormant Accounts (Amendment)
Bill 2004 was introduced in the Seanad, reforming
the processes by which decisions are made about
disbursements from the Fund. In 2003 the
Dormant Accounts Fund Disbursements Board
(DAFDB) published its first plan, covering the years
2003–05. The plan states that at least 40 per cent
of total annual funding will be allocated to the area
of economic and social disadvantage, and that,
after the first year, not less than 50 per cent of the
annual proportion allocated to economic and social
disadvantage will be allocated to RAPID, CLÁR and
drugs task forces. 
www.dormantaccounts.ie
In July the British–Irish Council published a
report on its work between 1999 and December
2003. The Irish government, with lead
responsibility for drugs, reports on the work
programme in relation to the drugs issue. The
Northern Ireland Executive, with lead responsibility
for transport, reports that it is considering the
potential for taking forward work on driving and
drug misuse within the Council.
www.britishirishcouncil.org
In July the Drug Treatment Centre Board
(DTCB) published its annual report for 2003. New
initiatives included piloting on-site hepatitis C
treatment for hepatitis-C-positive attendees, and
the development of dedicated, structured
programmes for the growing number of clients
who were presenting for treatment for cocaine use.
www.addictionireland.ie
In August Merchants Quay Ireland (MQI)
launched its annual report for 2003. It shows that
the numbers of drug users attending their Health
Promotion Unit continued to increase, up by 5 per
cent on 2002, to 3,331. MQI’s strategic plan for
2004–2006 sets out its plans for the direct
management of supported accommodation for
homeless drug users, to meet the needs of
homeless people and drug users in cities outside of
Dublin, and to develop new innovative harm
reduction services for homeless people and drug
users.
www.mqi.ie
In September the Drug Awareness Programme
(DAP) website, run by Crosscare, was awarded the
Dublin Bus Inaugural Award for Serving the
Community. The website offers on-the-spot
confidential advice about drug problems. The
website has already won the British Telecom
Telephone Helpline Award 2003/04. 
www.dap.ie
On 4 October a conference on ‘Exploring Drug
Issues through Community Research’ saw the
launch of four community research reports funded
by the National Advisory Committee on Drugs
(NACD). The launch was followed by a workshop
on the principles and practice of community
research. The four community research groups
funded by the scheme were the Ballymun Youth
Action Project (BYAP), the Kilbarrack Coast
Community Programme (KCCP), Merchants Quay
Ireland (MQI) and the Tallaght Homeless Advice
Unit (THAU). The reports will be discussed more
fully in the next issue of Drugnet Ireland.
www.nacd.ie
In brief Compiled by Brigid Pike
The then Minister for Health
and Children, Mr Micheál
Martin TD, at the launch in
July of the DTCB annual report
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The Health Behaviour in School-aged Children
(HBSC) survey is a cross-national research study of
the health and health-related behaviour of school-
going children carried out every four years. The
research is conducted by an international network
of research teams in collaboration with the World
Health Organization (WHO) Regional Office for
Europe. The most recent survey was conducted
successfully in 35 countries and regions, including
Ireland. Findings from the Irish survey, including
data on drug use, have been previously published.1
On 4 June 2004 the WHO published an
international report which used data from the last
HBSC survey.2 The report, Young people’s health in
context, provides information on the prevalence of
priority health-related behaviour and key health
indicators, and places these findings in their social
and developmental contexts. Previously
unpublished data on cannabis use by young people
in Ireland are presented in part of the report. The
section on cannabis use is authored by Tom ter
Bogt, Anastasios Fotiou and Irish researcher Saoirse
Nic Gabhainn.
The target population in the HBSC survey is school-
going children who are aged 11, 13 and 15 years.
The HBSC protocol recommends a minimum survey
sample size of 1,536 children at each of these ages.
In Ireland the numbers of children surveyed at
these ages were 1,012, 944 and 919 respectively,
which were lower than the desired targets. It
should be kept in mind that, in general, the smaller
the survey sample the wider are the confidence
intervals around the estimates obtained from the
sample.3 The protocol also required that children be
selected using a cluster sampling design, where the
initial sampling unit was the class (or school in the
absence of a sampling frame of classes). Each child
of the appropriate age in the classes selected and
present in class on the day of the survey was asked
to participate. In Ireland, individual schools within
regions were first randomly selected and classes
within schools were subsequently randomly
selected for participation. The objective was to
achieve a nationally representative sample of
school-going children. The Irish HBSC survey was
carried out between April and June 2002.
The findings on cannabis use presented in the
report relate only to 15-year-olds. The numbers of
children who responded to the cannabis questions
are not given in the report. Results for boys and girls
in Ireland compared with the average for all 35
HBSC countries and regions are shown in Table 1.
In Ireland one in every four boys reported using
cannabis in the year prior to the survey. The rate
was lower for girls: one in every seven had used
cannabis in the previous year. Cannabis use for
boys in Ireland was higher than the HBSC average,
while that for girls was lower. However, the
differences in the proportions are small and may be
due to sampling variation.4
Four groups were identified among those who
reported having used cannabis at least once in their
lives, based on the number of times they had used
it in the previous 12 months. The four groups were
‘former users’ who had not used cannabis in the
last year, ‘experimental users’ who had used it once
or twice, ‘recreational users’ who had used it
between 3 and 39 times, and ‘heavy users’ who
had used it 40 or more times. The percentage of
young people in Ireland in each of these four
groups compared with the HBSC average is shown
in Table 2.
Cannabis use by young people in Ireland
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Table 1
Boys aged 15 years Girls aged 15 years
Ireland HBSC average Ireland HBSC average
% % % %
Cannabis use
During lifetime 27.3 25.8 15.2 18.4
During last year 25.5 21.7 14.4 16.0 
Source: Young people’s health in context (p. 86)
Table 2
Children aged 15 years
Ireland HBSC average
% %
Former user 1.5 3.6
Experimental user 7.9 7.3 
Recreational user 6.4 7.9 
Heavy user 3.6 2.8 
Source: Young people’s health in context (p. 88)
In Ireland one in
every four boys
reported using
cannabis in the
year prior to the
survey.
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Compared to the HBSC average, Ireland had a
much lower percentage of ‘former users’,
suggesting that young children in Ireland are more
likely to continue their use after starting. Indeed, of
the 35 HBSC countries and regions, Ireland ranked
30th on this indicator. The percentage of
experimental cannabis users in Ireland was slightly
higher than the HBSC average, while the
percentage of recreational users was lower. Of most
concern was the level of heavy cannabis use: a
higher percentage of children in the sample in
Ireland had used cannabis 40 or more times in the
last year (3.6%) than the average for all samples in
the 35 HBSC countries and regions (2.8%). The
report notes that, while most users in all HBSC
countries and regions belonged to the experimental
and recreational use groups, the ‘small numbers
reporting heavy use at this stage of their lives may
well be at risk of adverse health and social
consequences and should be the focus of targeted
interventions’. (Hamish Sinclair)
1. Kelleher C et al. (2003) The National Health & Lifestyle
Surveys. Survey of Lifestyle, Attitudes and Nutrition (SLÁN) &
the Irish Health Behaviour in School-aged Children Survey
(HBSC). Galway: Centre for Health Promotion Studies,
National University of Ireland.
2. Currie C et al. (eds) (2004) Young people’s health in
context. Health Behaviour in School-aged Children (HBSC)
study: international report from 2001/2002 survey.
Copenhagen: World Health Organization.
3. A confidence interval is a range of values which we can be
confident includes the true value. By convention, a 95%
confidence interval is reported. For example, if the
proportion of cannabis users in a survey sample drawn from
the population is found to be 17% and the 95% confidence
interval is reported as ranging from 14% to 20%, then we
can say that we are 95% confident that this interval includes
the true proportion of cannabis users in the population. It is
good practice to provide confidence intervals to indicate the
level of precision associated with survey estimates.
4. Because researchers must normally take a sample rather
than study an entire population, inaccuracies can occur in
making inferences about a population value based on a
sample value. Sampling variation or sampling error is an
estimate of how much a sample value can be expected to
differ from the true value in the population. The difference
expected is accounted for by the level of precision chosen
when calculating the sample size. Thus, differences
observed between two estimated proportions may simply
be due to a lack of precision.
The National Advisory Committee on Drugs
recently published An overview of scientific and other
information on cannabis.1 The report draws on
relevant research from Ireland and abroad with a
view to presenting a balanced account of how this
illegal but widely used substance affects a range of
outcomes. The review was conducted by four
authors, from four different disciplines. 
The pharmacological and toxicological effects of
cannabis were considered by Dr Dominique
Crowley.1 The identification through laboratory
studies of two cannabis receptors in the brain,
linked to memory, movement and co-ordination,
pain perception and the reward system, has
resulted in a better understanding of cannabis
effects in humans. The potential therapeutic value
of cannabis compounds is difficult to assess, as a
specific ‘dose’ of cannabis cannot be reliably
administered. There is only anecdotal evidence to
suggest that cannabis may have beneficial effects
on mood disorders, but cannabis and its derivatives
can be useful in the treatment of pain and nausea.
There is a strong association between cannabis use
and some mental health problems; people suffering
from a depressive condition are much more likely
to become heavy users of the drug than those
without such a diagnosis.
Dr Crowley also examined the connection between
cannabis use and short-term memory loss, cardiac
problems and respiratory conditions. Evidence of a
link between cannabis use and cancer and
antenatal health problems has not been firmly
established.
Dr Claire Collins reviewed the epidemiological
evidence concerning the public health risks of the
drug. Prevalence rates for cannabis use are highest
among the 15–24 year age group, with over three-
quarters of 16-year-olds saying they know where to
obtain the drug and relatively low proportions
perceiving cannabis use as risky behaviour. In about
80 per cent of cases, young people try out cannabis
for the first time with their friends. 
There is a strong statistical association between
cannabis use during adolescence and subsequent
use of other illicit drugs. However, most young
people who try cannabis do not progress to either
heavy cannabis use or the use of other illicit drugs.
Another public health consequence of cannabis use
is its association with traffic accidents, where it can
often combine with alcohol as a contributory factor.
Dr Mark Morgan examined the psychological
consequences of cannabis use. While there is little
evidence that cannabis use has an impairing effect
on cognitive functioning as measured by IQ tests,
heavy cannabis use produces subtle cognitive
Cannabis use by young people in Ireland (continued)
impairments of memory, attention and the
organisation of complex information.
It is often suggested that cannabis induces
‘amotivational syndrome’ where users appear to be
apathetic, lethargic and unmotivated. However,
recent studies have failed to find clear-cut evidence
for this syndrome. A strong association between
cannabis use and poor educational outcomes is a
firmly established finding in the literature.
There is consistent evidence that young people
attempting suicide are more likely to have a history
of heavy cannabis use than are others. However,
personality make-up and the presence of other
substances must be considered when attempting to
define the contributory role of cannabis. 
Mr Johnny Connolly examined the criminological
and sociological consequences of cannabis use.
Many of the negative criminological and
sociological consequences related to cannabis have
been attributed to its legal status, rather than to
any properties of the drug itself. The debate over
cannabis law reform remains one of the most
contested areas of international drug policy. The
legal status of cannabis has come under increased
scrutiny in recent years in Ireland. The National
Crime Forum, established by the Minister for
Justice, Equality and Law Reform in 1998, heard
arguments for and against the decriminalisation of
cannabis.2 The recent declassification of cannabis in
the United Kingdom has contributed to further
debate on the subject.3
Cannabis is the most widely trafficked drug
globally. In Ireland, as in most other countries,
there are more seizures of cannabis than of any
other drug. In 2002, cannabis-related seizures
accounted for 54 per cent of the total number of
drug seizures for that year and An Garda Síochána
figures show a steady increase in the total number
of cannabis-related offences in recent years.4
Cannabis-related offences accounted for 64 per
cent of the total number of offences in which
criminal proceedings commenced in 2002.
This section also looks at the effect that drug laws
have had on educational and employment
prospects, relationships and travel in a number of
countries. Cannabis laws can contribute to
marginalisation and alienation, inducing a
perspective among young people that the law is
unfair, heavy-handed and out of touch. 
It is difficult to establish the precise causative link
between drug use and crime, aside from the
obvious link to drug offences such as possession
and supply. Recent studies have found an
association between heavy use by juveniles and
aggressive behaviour. A recent UK review
concluded that those who use illicit drugs are more
likely to be involved in crime, and vice versa.
Although there is clear evidence of violence
associated with the drug trade, in the absence of
any adequate studies of Irish drug markets it is
impossible to state with any clarity the extent to
which violence is associated specifically with the
trade in cannabis. 
The gateway theory holds that, although most
cannabis users do not progress to other drugs,
cannabis primes the user into taking other illicit
drugs, either through a physiological mechanism or
through personality and social factors. Among the
factors which have been identified as increasing the
probability of further harm are early onset of
cannabis use, family and other problems, exposure
to other illicit drug markets, and alcohol and
tobacco consumption. Age and gender are also
important factors.
Many countries have sought to address the
gateway factor by introducing changes in cannabis
law enforcement practices or through legal reforms.
The chapter concludes by highlighting the need for
further research in the drugs–crime area in Ireland.
There is a particular need for more data describing
the way in which laws are being implemented in
the area of drug markets. (Johnny Connolly)
1. Collins C, Connolly J, Crowley D & Morgan M (2004) An
overview of scientific and other information on cannabis.
Dublin: National Advisory Committee on Drugs
2. Government of Ireland (1998) National Crime Forum
Report. Dublin: Institute of Public Administration.
3. For an analysis of the legal changes in the UK see
Connolly J (2004) Reclassification of cannabis in the UK,
Drugnet Ireland, Issue 10, March 2004.
4. See An Garda Síochána Annual Reports for 1999 to 2002.
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Between 1997 and 2000, the Irish Prison Service
commissioned a number of studies to examine the
prevalence of blood-borne viruses1,2 and the health
status of the prison population.3 Two independent
qualitative studies were also completed.4,5,6
In the late 1990s, two studies1,2 estimated the
prevalence of antibodies to hepatitis B, hepatitis C
and HIV among the prison population and
described the risk factors associated with testing
positive for each of these antibodies. 
Among 1,193 prison inmates in 19981 the
prevalence of antibodies to the hepatitis B core
antigen was 9 per cent, to hepatitis C 37 per cent,
and to HIV 2 per cent; two-fifths of prisoners tested
positive for one or more of the infections. Of the
1,178 inmates whose injecting status was known,
43 per cent (509) had ever injected and, of these,
one-fifth had started injecting in prison. 
In order to adjust for the over-representation of
prisoners serving longer sentences and to ensure
adequate representation of prisoners held on
remand or serving shorter sentences, a survey
estimating the prevalence of blood-borne viruses
among 596 prison entrants was completed in
1999.2 The prevalence of antibodies to hepatitis B
core antigen was 6 per cent, to hepatitis C 22 per
cent, and to HIV 2 per cent. One-third of the
respondents had never previously been in prison
(197); these had the lowest prevalence of
antibodies to hepatitis B core antigen (2%), to
hepatitis C virus (3%) and to HIV (0%). In total,
173 (29%) entrants reported ever injecting drugs.
Only 7 per cent (14/197) of those entering prison
for the first time reported ever injecting drugs,
compared to 40 per cent (157/394) of those
previously in prison. Of those who ever injected
and had spent time in prison, 19 per cent started
injecting in prison. 
In the two studies,1,2 the overall pattern of injecting
drug use was similar among both inmates and re-
entrants. The prevalence of antibodies to all three
viruses was significantly higher among both
inmates and entrants who reported injecting drug
use (Figures 1 and 2). 
After adjusting for other risk factors in both studies,
injectors who had shared needles in prison were
over four times more likely to test positive for
hepatitis C than injectors who had not shared
needles in prison. Injectors who started injecting
more than three years prior to the survey were also
more likely to test positive for hepatitis C than
injectors who had not injected in the month prior
to the survey. Injectors who had spent more than
three of the last 10 years in prison were also more
likely to test positive for hepatitis C than their
counterparts who had spent less than three months
in prison. 
The authors of the two studies concluded that
hepatitis C was endemic in Irish prisons, that
injecting drug use was the most important risk
factor, and that being in prison would seem to
increase the risk of acquiring it. 
Long and colleagues described and explored
injecting practices,4 strategies taken to deal with
risk of infection5 and actions necessary to address
this situation;4 31 (16 injectors and 15 non-
injectors) participants were interviewed. 
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Figure 1   
Prevalence of antibodies to hepatitis B, hepatitis C and
HIV among prison inmates, by injector status, in 1998
Figure 2   
Prevalence of antibodies to hepatitis B, hepatitis C and
HIV among prison entrants, by injector status, in 1999
Injectors reported and non-injectors observed that
‘injectors take a number of risks during detention
that they would not take outside prison’. For
example, the low availability of heroin encouraged
the change from smoking to injecting; the scarcity
of injecting equipment meant that sharing circles
were far wider than outside prison; cleaning
practices were inadequate for injecting equipment;
and those who owned a syringe and needle rented
them to other injectors as a means of acquiring the
drugs to maintain their habit. The non-injectors in
prison said they knew which prisoners were current
injecting drug users. Almost all non-injectors had
observed injecting drug use in prison and their
reported observations of injecting practices were
consistent with those reported by respondents who
had injected in prison. 
During the in-depth interviews, prisoners (both
injectors and non-injectors) were asked how they
dealt with the risk of either contracting or testing
positive for hepatitis C. Two dominant themes
emerged: denial and fear. Injector respondents
dealt with the possibility of contracting or
experiencing consequences of infection with
hepatitis C by: living in the moment; distancing its
effects in time; generalising the condition to all
injectors; and comparing its consequences to those
of HIV. This process allowed them to continue
injecting without considering the consequences.
According to most injector respondents, hepatitis C
is common among those who inject drugs and, to
date, its consequences have not been serious. 
The fears expressed by injectors and non-injectors
were in the main well founded. Fear of contracting,
or actually contracting, blood-borne viruses
deterred a number of heroin users from starting or
continuing to inject heroin in prison. Similar
numbers of non-injector and injector respondents
reported that they feared contracting blood-borne
viruses while in prison. 
All respondents were asked: ‘What action is
required by the prison authorities to deal with drug
use in prison?’ Respondents suggested a number of
interventions, including routine daily activities (such
as education, work, and exercise), drug awareness
programmes, individual counselling sessions and
harm reduction services. Non-injectors were
sympathetic to the plight of injectors, and both
non-injectors and injectors supported harm
reduction interventions and thought that the range
of drug services in prison should mirror that
currently available in the community, although half
opposed or had reservations about needle
exchange. 
Prisoners viewed time in prison as an opportunity to
address substance misuse and stabilise viral infections;
health professionals should not miss this opportunity.
Hannon et al. (2000) documented the health status
of prisoners in Ireland, including their mental health
status.3 The high rate of lifetime drug use (72%
males, 83% females) occurred in a population that
reported many mental health problems. In the
clinical history section of this study, 30 per cent of
male and 49 per cent of female respondents stated
that they had spoken to a health professional about
anxiety, depression or a mental, nervous or
emotional problem in the past 12 months. Of these,
42 per cent of males and 58 per cent of females had
sought help for depression, 13 per cent of males and
4 per cent of females for anxiety, and 14 per cent of
males and 29 per cent of females for drug-related
problems. Overall, 24 per cent of male prisoners and
34 per cent of female prisoners reported attending a
health professional at the time of interview; of these,
17 per cent of males and 37 per cent of females
were attending a psychiatrist. The association
between psychiatric illness and problem drug use
among prisoners was not examined in this study, but
there is anecdotal evidence of a clear overlap
between problem substance use and mental illness. 
During 2000 and 2001 the Irish Prison Service,
along with other agencies, examined the findings
of these studies and developed both drug
treatment service plans and healthcare plans for the
prisoners.7,8 By the end of 2002, the Prison Service
was at an advanced stage of drafting an Irish Prison
Drug Service Policy that would be in line with the
current Irish drugs strategy Building on Experience:
the National Drugs Strategy 2001– 2008
(Department of Tourism Sport and Recreation
2001) and the World Health Organization’s Health
in Prisons Project: Prisons, Drugs and Society 2002.9
This policy is awaiting approval from the Minister
for Justice, Equality and Law Reform. 
A number of positive developments have ensued,
such as the introduction of evidence-based
methadone treatment services that can be accessed
by the majority of opiate-dependent prisoners. The
Irish Prison Service is to be commended for its
attempts to vaccinate a significant minority of
prisoners against hepatitis B, something very few
prisons, nor, indeed, community health services,
have managed. The employment of registered
nurses facilitated the separation of disciplinary and
healthcare roles, although more needs to be done.
The increased availability of drug-free units is also to
be commended. 
There is, of course, much more to do, such as harm
reduction methods for those who continue to inject
(for example, safe injecting information and limited
needle exchange) and the management of
morbidity (hepatitis C and sexually transmitted
infections) associated with drug misuse. Counselling
and psychological services are also necessary in Irish
prisons and the feasibility of introducing the
therapeutic community model of care for those who
Drug situation, consequences and treatment in Irish
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wish to address their substance misuse should be
considered. The high levels of psychiatric co-
morbidity are also worrying and indicate that a
mental health strategy that is linked to the drug
treatment service is urgently required. 
The prison authorities and their healthcare staff have
made large strides towards improving access to
some drug treatment and healthcare services but,
sadly, there is very little documentary evidence
because of the failure to use the existing
conventional health information system; this is a
missed opportunity. (Jean Long)
1. Allwright S, Bradley F, Long J, Barry J, Thornton L and
Parry JV (2000) Prevalence of antibodies to hepatitis B,
hepatitis C and HIV and risk factors in Irish prisoners:
results of a national cross sectional survey. British Medical
Journal, 321: 78–82.
2. Long J, Allwright S, Barry J, Reaper-Reynolds S, Thornton
L, Bradley F, Parry JV (2001) Prevalence of antibodies to
hepatitis B, hepatitis C, and HIV and risk factors in
entrants to Irish prisons: a national cross sectional survey.
British Medical Journal, 323: 1209–1213. 
3. Hannon F, Kelleher C, Friel S, Barry M, Harrington J,
McKeown D, and McMahon A (2000) General healthcare
study of the Irish prison population. Galway: National
University of Ireland.
4. Long J, Allwright S, Begley C (2004) Prisoners’ views of
injecting drug use and harm reduction in Irish prisons.
International Journal of Drug Policy, 15: 139–149. 
5. Long J, Allwright S and Begley C (2003) Fear and denial:
how prisoners cope with risk of or diagnosis with hepatitis
C (abstract). Irish Journal of Medical Science, 172(2)
Supplement 1: 27. 
6. Dillon L (2001) Drug use among prisoners: An exploratory
study. Dublin: Health Research Board.
7. Irish Prison Service (2000) Report of the steering group on
prison-based drug-treatment services. Dublin: Department
of Justice, Equality and Law Reform.
8. Group to Review the Structure and Organisation of Prison
Health Care (2001) Report of the group to review the
structure and organisation of prison health care services.
Dublin: Stationery Office.
9. Irish Prison Service (2003) Irish Prison Service Annual Report
2002. Dublin: Stationery Office.
The National Advisory Committee on Drugs
(NACD) commissioned Moore and colleagues1 at
Dublin City University to review the international
evidence for harm reduction approaches and the
availability of such approaches in Ireland. This
article will concentrate on the section of that review
that profiled harm reduction services in Ireland. For
the purpose of the review, a harm reduction
approach was defined as one ‘that focuses on
reducing the harm that substance misusers do to
themselves and their families.’ The aim of such
approaches was ‘to reduce the transmission of HIV,
hepatitis and other infectious diseases and to
maximise service users’ health.’ The harm reduction
approaches asked about in the study were needle
exchange (including types of injecting equipment
distributed), methadone maintenance, replacement
drugs, smoking or snorting pipes, and provision of
information on safer injecting. Methods to prevent
or manage overdose were not specifically examined
in the study, nor was the availability or uptake of
hepatitis B vaccine.
With assistance from the regional drug co-
ordinators and area operations managers, a
purposeful sample of services and key informants
(n=16) was chosen to take part in a thirty-minute
telephone interview. The telephone interview was
administered using a pre-tested questionnaire
containing a combination of open and closed
questions. The 16 service providers interviewed,
comprised nine who worked in the Eastern Regional
Health Authority (ERHA) area and one from each of
the remaining seven health boards. Three
informants from outside the ERHA reported that
their work did not include harm reduction with
drug users who used paraphernalia to administer
drugs and these interviews were discontinued at
that stage. It was unusual that three participants
selected in a purposeful sample had no experience
working with injecting drug users, since such drug
users live and are treated in each health board area.
This limited the researchers’ ability to provide a
national picture.
The nine service providers working in the ERHA
area reported working with injecting drug users,
mainly opiate users. In addition, three service
providers worked with cocaine users. Some service
providers also reported treating cases reporting
problem benzodiazepine use. According to service
providers outside the ERHA area, the main problem
substances were alcohol, cannabis and ecstasy. 
All services providers in the ERHA area reported that
methadone maintenance and one-for-one needle-
Drug situation, consequences and treatment in Irish
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exchange facilities were available in their area. With
the exception of filters, all other types of injecting
equipment were provided to clients attending these
services. Half of the service providers in the ERHA
area reported that filters were not available at their
service. In contrast, service providers outside the
ERHA area stated that methadone maintenance was
the mainstay of their harm reduction services and
no injecting equipment was distributed. Pipes were
not provided at any service in Ireland. 
All service providers in the ERHA area and a tiny
minority outside the area reported providing
information on specific injecting techniques and
care of an injection site. The service providers in the
ERHA area also advised clients on safer smoking and
polydrug use. 
With respect to health promotion practices, the
majority of service providers in the ERHA area said
that their services provided information and
demonstrations on safer injecting practices in line
with current evidence. The authors do not report
whether such interventions were provided by
services outside the ERHA area. 
On a national basis, the vast majority of service
providers reported that the main purpose of harm
reduction approaches was to reduce the harm that
drug users did to themselves. Some service
providers reported that harm reduction services
reduced the transmission of infectious diseases. Two
services providers mentioned that harm reduction
services were a pathway to other health care
services. Half of the health service providers in the
ERHA area reported that these services promoted
safer injecting practices. 
All service providers reported similar vulnerable
groups, such as women, children and homeless
clients. In addition, service providers reported that
priority groups included polydrug users, those with
mental illness, and those testing positive for HIV. It
is interesting to note that those testing positive for
hepatitis C were not regarded as a priority or
vulnerable group. Yet, it is accepted that hepatitis C
is common among injecting drug users, that co-
infection between hepatitis C and HIV leads to
more aggressive liver disease, and that individuals
with co-infection have a poorer prognosis than
those with a single blood-borne viral infection. 
All of the service providers in the ERHA area and
half of those outside it reported that specific issues,
such as blood-borne viruses, localised bacterial
infections at injection sites and sexual health, were
addressed in their programmes. It is not clear from
the research the extent to which these issues were
addressed. 
According to the service providers both in and
outside the ERHA area, services were normally
available without appointment and were mainly
provided during office hours, with a small number
opening in the evenings (in the ERHA) and at
weekends (methadone services outside the ERHA).
The service providers said that the main means of
advertising was by word of mouth. Services were
also advertised through published directories and
posters in clinics. 
All service providers reported either formal or
informal links with other health and social care
services. Many reported working closely with
persons from the justice system. The service
providers in the ERHA area reported links with self-
help groups. 
In general, service providers in the ERHA area
reported that policy did translate into practice,
although the majority stated that there were
occasions when they had to ‘bend the rules’ to
facilitate patient care. In contrast, the majority of
service providers outside the ERHA area reported
that policy did not translate into practice, and
unofficial practices occurred at one service, in that
needles, syringes and condoms were distributed. 
The service providers in the ERHA suggested a
number of developments to improve the current
service, such as: 
■ Expansion of outreach work
■ Greater access to low threshold services
■ Increased variety of needle exchange outlets
■ Adaptation of current services to deal with
cocaine
■ Provision of respite houses 
■ Greater inter-agency collaboration
The service providers outside the ERHA area
requested:
■ An increase in resources
■ Clear policies and structures with respect to
needle exchange and methadone maintenance
■ Evidence based practice in relation to harm
reduction interventions
■ Strategies to reduce waiting lists for treatment
■ Community-focused outreach services
(Jean Long)
1. Moore G, McCarthy P, MacNeela P, MacGabhann L,
Philbin M, Proudfoot D (2004) A review of harm reduction
approaches in Ireland and evidence from the international
literature. Dublin: Stationery Office.
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Methadone treatment has become the most
common form of opioid substitute treatment and,
as such, is the most extensively researched
intervention worldwide. Internationally, there is
evidence to suggest that methadone treatment can
reduce drug-related morbidity and mortality and
improve a person’s health and social well-being.
There are a limited number of studies measuring
aspects of the effectiveness of methadone as a
treatment for problem opiate use in Ireland. Cox
and Lawless (2004)1 undertook an evaluation of a
methadone prescribing service in Dublin City ‘to
examine the role which prescribed methadone
plays within the lives of a cohort of opiate-
dependent individuals in Dublin City.’ 
The study employed a mix of quantitative and
qualitative methods. 
The quantitative study followed a cohort of
individuals who entered a methadone maintenance
programme in 1999 and continued in treatment for
an 18-month period. A validated questionnaire,
known as the opiate treatment index, was
administered to 33 clients at some time following
entry to methadone treatment at Merchants Quay
Ireland in 1999 and to 17 clients who were still in
treatment 18 months later. The questionnaire
collected self-reported data on six domains: drug
use, HIV risk-taking behaviours, social functioning,
criminality, health status and psychological
adjustment. Excluding social functioning, the data
collected for all other outcomes was based on
behaviours in the month prior to each interview.
The data on social functioning pertained to
behaviours in the six-month periods prior to each
interview. Each domain had a number of questions,
with a number of answer options. Each answer
option had a score, with the lowest score indicating
the lowest level of risk-taking or the best
experience. The questionnaire collected some
additional data on each client’s demographic and
social situation. 
The main findings between baseline and follow-up
study were: 
■ The mean opiate treatment index scores for
HIV-related risk behaviours increased
(accounted for by an increase in reported sexual
risk behaviours rather than in drug-using risk
behaviours) in the month prior to the follow-up
study, compared to respective risk behaviours
reported at the time of the baseline study. 
■ Criminal behaviour decreased substantially, with
only one client reporting committing one or
more crimes during the month prior to the
follow-up study, compared to six clients
reporting similarly at the time of the baseline
study.
■ Social functioning scores decreased
considerably, indicating an improvement in
housing, employment and family relationships
at the time of the follow-up study, compared to
the baseline study. 
■ Health status remained similar. 
■ Psychological adjustment scores decreased,
indicating that mental health outcomes had
improved over the 18-month period. 
It is important to note that the sample size was
small and that the improvements in mean scores
were not tested statistically. Nevertheless, the
findings suggest a number of positive outcomes
associated with methadone maintenance therapy. 
The qualitative study consisted of three focus
groups. These were undertaken to ascertain the
experiences of clients and service providers with
respect to methadone maintenance. Two focus
groups were carried out to ascertain the
experience of clients who attended the
methadone prescribing service or the day
programme at Merchants Quay Ireland. Those
who attended the day programme were
receiving methadone maintenance in a health
board clinic or general practice setting. The
clients were asked about methadone
maintenance and continued risk behaviour, use
of counselling and other auxiliary services,
impact of methadone on their lives, and their
relationship with service providers. The third
focus group comprised staff working in the
methadone prescribing service or the day
programme at Merchants Quay Ireland. The
service providers were asked about the positive
and negative aspects of methadone
maintenance, issues that positively and
negatively affect treatment outcomes, and other
pharmaceutical treatment options. 
Five themes were identified in the data transcribed
from the focus groups:
■ Theme 1 ‘Key players in methadone treatment’
Clients welcomed the improvements in drug
treatment services following the introduction of
the methadone protocol, particularly the
increase in the number of places available, the
removal of all financial charges, the wide range
of services available in the clinics for the less
stable patients, and the transfer of stable
patients to general practice settings. The clients’
experiences at pharmacies were both positive
and negative. The negative experiences were
long waiting periods, lack of privacy and poor
communication between the general
practitioner and the pharmacist. 
Outcomes and experiences of methadone
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■ Theme 2 ‘Methadone treatment and
integration’ 
The transition between active drug use and
stabilising on methadone maintenance is a very
vulnerable time for drug users. Clients reported
that structured day programmes and formal
training programmes provided them with a
regular routine and the skills to gain future
employment. Many who were employed
reported that it was very difficult to meet the
competing requirements of both a full-time job
and the methadone treatment services. In
general, those with full-time work feared that
their employers would discover that they were
on a methadone treatment programme and that
they would lose their position. The majority of
clients reported that methadone maintenance
improved their relationships with their families
and decreased their criminal activity. 
■ Theme 3 ‘Responding to methadone’
Clients reported that, initially, methadone
maintenance was very important when moving
from active drug use to no drug use, but that
they now worried about the long-term
dependence on methadone itself. Some clients
who were stable on long-term methadone
maintenance expressed a desire to detoxify but
feared that they would find it difficult to
tolerate the withdrawal symptoms, or that they
would relapse into heroin use. They also
reported that service providers did not
encourage them to detoxify but to maintain
status quo. Clients requested that a broader
range of detoxification methods be provided for
those wishing to detoxify from methadone
maintenance and that service providers facilitate
their provision. 
■ Theme 4 ‘Managing methadone treatment’
Most clients reported that the high turnover of
counsellors at drug treatment centres was
disruptive in maintaining a stable lifestyle or
dealing with crises. The clients accepted that
their drug use had to be monitored but asked
for an alternative to urinalysis, as it was
humiliating for both clients and service
providers. 
■ Theme 5 ‘Methadone and health’
Many clients on methadone reported dental
problems that they associated with their
methadone therapy. Many also reported that
opiates were not their only problem drugs, with
some reporting dependence on other
prescribed drugs, such as benzodiazepines,
hypnotics and tranquillisers. The clients also
reported interactions between antiviral therapy
and methadone. 
Overall, the two elements of the study suggest that
methadone maintenance therapy was successful in
stabilising heroin users and in assisting them to
establish a positive lifestyle. The provision of
services at primary care increased the number of
places and removed some of the stigma associated
with drug dependence. Clients reported that the
monitoring of drug use by urinalysis was
humiliating and recommended that other methods
be introduced. The studies highlight some of the
issues that inhibit successful treatment, such as
polydrug use, mental illness and infection with HIV
or hepatitis C, and recommend comprehensive
services to deal with these issues. The clients
requested that service planners and providers
develop a wide-ranging approach to assist those
who wish to detoxify from long-term methadone
maintenance. (Jean Long)
1. Cox G and Lawless M (2004) Maintaining or enabling?
Evaluation of a methadone prescribing service in Dublin
City. In Pieces of the jigsaw: six reports addressing
homelessness and drug use in Ireland. Dublin: Merchants
Quay Ireland.
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Driving under the influence of drugs has been a
statutory offence in Ireland since the Road Traffic
Act 1961. The principal legislation in this area is
covered under the Road Traffic Acts 1961 to 2002.
Section 10 of the Road Traffic Act 1994 prohibits
driving in a public place while a person ‘is under
the influence of an intoxicant to such an extent as
to be incapable of having proper control of the
vehicle’. Intoxicants are defined to include alcohol,
drugs, or any such combination. The Medical
Bureau of Road Safety (MBRS) is the independent
forensic body responsible for chemical testing of
intoxicants under the Road Traffic Acts.
A recent nationwide survey carried out by the
MBRS in 2000 and 2001 included an analysis of
seven drugs or drug classes in 2,000 blood and
urine samples taken from drivers suspected of
intoxicated driving.1 Of the 2,000 specimens
chosen, 1,000 were under the legal limit for alcohol
and 1,000 were over. The drugs involved were:
amphetamines, metamphetamines,
benzodiazepines, cannabinoids, cocaine, opiates
and methadone. The purpose of the study was to
determine current trends in driving under the
influence of drugs (DUID) in Ireland and also to
establish an evidence-based model to inform future
road safety strategies.
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The results suggest that there is a significant DUID
problem in Ireland. Sixty-eight per cent of tested
drivers with essentially zero levels of alcohol were
positive for one or more drugs, suggesting a strong
trend of increasing drug positivity with decreasing
levels of alcohol. Cannabinoids were the most
common drug class encountered. The study found
no significant gender difference in the overall drug-
positive results, although over 90 per cent of
apprehended drivers were male. The typical profile
of the apprehended and tested DUID driver is
young, male, driving in an urban area with a low or
zero alcohol level, with a specimen provided
between the hours of 6 am and 9 pm and with a
presence of cannabinoids. The study also identified
a pattern of middle-aged drivers under the
influence of benzodiazepines – a legally prescribed
drug which can also impair driving.
The authors conclude that the study highlights the
need for an education and awareness campaign in
relation to DUID. There should also be an
emphasis, they suggest, on the dangers associated
with driving while under the influence of prescribed
drugs. The study recommends that if the Gardaí
suspect a case of DUID and obtain a negative or
low alcohol reading then they should take a
separate blood or urine specimen so as to detect
the presence of a drug or drugs other than alcohol. 
One of the outcomes of the MBRS study will be an
evidence-based review of the legislation on driving
under the influence of drugs. The study also
highlights the difficulties of law enforcement in this
area, and concludes that, ‘the goal of producing a
valid, reliable and convenient roadside testing device
for drugs is still paramount and not yet achieved’.2
A limitation of the study is that no random
sampling of motorists occurred. Given that all of
the blood and urine samples were taken from
drivers apprehended by the Gardaí and suspected
of driving under the influence of an intoxicant, the
authors conclude that the information ‘does not
provide a full picture of use of drugs in the general
driving population’.3 (Johnny Connolly)
1. Cusack D, Leavy P, Daly L and Fitzpatrick P (2004) Driving
under the influence of drugs in Ireland: results of a
nationwide survey. Dublin: Medical Bureau of Road Safety.
2. Ibid, p. 2.
3. Ibid, p. 6.
The Irish Presidency of the EU between January and
June 2004 saw considerable activity in the drugs
field, including the following:
■ EU Drugs Strategy 2005–2012 A
preparatory conference ‘EU Strategy on Drugs –
The Way Forward’ was held in Dublin on 10/11
May. The European Council welcomed the
conclusions of the conference, and the Dutch
Presidency is now tasked with drafting the new
strategy with a view to its adoption no later
than December 2004. A summary of the main
elements discussed at the Dublin conference is
available (9595/04 CORDROGUE 36 REV 1).  
■ New Narcotic and New Synthetic Drugs –
Proposal for a Council Decision on
Information Exchange, Risk Assessment
and Control The Irish Presidency prioritised
discussion on this proposal from the European
Commission, with a view to obtaining
agreement on a new joint action, revising the
1997 joint action. The text was agreed except
for the scope of the instrument and its legal
base. These issues are to be addressed under
the Dutch Presidency. The original Commission
proposal and subsequent documents are
available (13821/03 CORDROGUE 90; 9152/04
CORDROGUE 30; 10431/04 CORDROGUE 42). 
■ Supply/Demand Reduction and Synthetic
Drugs – Action Plans The Presidency received
an update on the implementation of plans in
the areas of supply/demand reduction and
synthetic drugs. A report is available (10481/04
CORDROGUE 43 + COR 1). The Presidency also
convened a brainstorming session on the issue
of data collection and interpretation in the area
of forensic analysis and profiling. The outcome
of this session is available (6204/04
CORDROGUE 21). 
■ National Co-Ordinators in the enlarged
EU The Irish Presidency hosted the first meeting
of the national drugs co-ordinators in the
enlarged EU, held on 15 June. Among other
matters, the meeting examined the issue of
cocaine, hearing presentations from the
European Monitoring Centre on Drugs and
Drug Addiction (EMCDDA) and the Irish
National Advisory Committee on Drugs
(NACD). 
■ 47th Session of Commission on Narcotic
Drugs (CND) The Irish Presidency co-ordinated
the positions of the member states and
accession countries in relation to resolutions put
forward at the 47th session of the CND, held in
Vienna in March. Ireland delivered eight
statements in plenary sessions of the CND on
behalf of the EU and acceding countries;
sponsored an EU resolution on ‘Optimising
Integrated Drug Information Systems’, which
was adopted by the plenary session; and co-
Drugs and driving (continued)
sponsored a further nine resolutions on behalf
of the EU and acceding countries. 
■ International Relations The Irish Presidency
prepared and co-chaired a series of high-level
meetings with the EU’s international partners in
the drugs field, including Latin America and the
Caribbean, the Andean Community, Iran, and
the Western Balkans. (Brigid Pike)
The National Drugs Strategy Unit in the Department of
Community, Rural and Gaeltacht Affairs supplied the
information on which this news item is based.  The documents
cited in this article are available on the Council of the
European Union’s archive at http://register.consilium.eu.int/
Irish EU Presidency and the drugs issue (continued)
Government Progress Report 2004: 
the drugs issue
drugnet Ireland
In August the government published its second
annual progress report on An Agreed Programme for
Government (June 2002). Progress on drug-related
priorities and targets includes the following:
Supply reduction
Progress is reported in developing a co-ordinating
framework within each Garda District, to liaise with
the community on drug-related matters and to act
as a source of information for parents and members
of the public.
■ A co-ordinating framework linking Garda
District, Divisional and National Drug Policing
Plans is currently being put in place by the
Garda authorities. 
■ The Garda Síochána Bill 2004 (published in
February 2004) provides for the development of
Joint Policing Committees at local-authority
level and for the establishment of local policing
fora in designated areas under the umbrella of
such committees. 
■ These bodies are to act as fora where matters
relating to local issues of policing and crime,
including drug-related issues, can be discussed
and where strategies and recommendations for
dealing with issues locally can be formulated.
■ A pilot Community Policing Forum initiative in
Dublin’s North Inner City has now been
positively evaluated and has been approved for
mainstreaming from January 2005 in
accordance with procedures under the National
Drugs Strategy. Other such fora are being
supported on a pilot basis.
Drugs in prisons
■ The draft Prison Drugs Policy currently being
considered includes provision for treatment,
rehabilitation and mandatory drug testing. 
■ Measures continue to be taken to reduce
supply, for example, searching procedures,
physical security including nets over exercise
yards, CCTV in visiting rooms and new visitor
procedures.
■ A new set of Prison Rules, which will make
provision for mandatory drug testing, is
currently with the Office of the Parliamentary
Counsel.
Prevention
■ The 10 Regional Drugs Task Forces (RDTFs)
have been established. They are currently
working on mapping out the patterns of drug
misuse in their areas, as well as services,
including prevention, already available, with a
view to co-ordinating these existing services
and addressing gaps in service provision. Their
plans are expected to become operational from
mid-2005.
■ The Department of Education and Science has
established eight regional offices and a further
two are due to be established before the end of
2004. Personnel from these offices will
represent the Department on the RDTFs and,
where relevant, on the Local Drugs Task Forces
(LDTFs). Appointments have been made by the
Department to six of the ten RDTFs and the
remaining four appointments will be made by
the end of 2004.
Treatment
■ Health boards are continuing to work towards
achieving immediate access for drug misusers
to professional assessment and counselling,
followed by commencement of treatment as
deemed appropriate, not later than one month
after assessment. The Progress Report states
that direct access to counselling and assessment
is in place, especially in larger urban centres.
■ There has been an increase in the numbers of
16
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general practitioners and pharmacists involved
in the delivery of drug treatment. At the end of
March 2004, there were 309 general
practitioners and 298 pharmacists participating
in the scheme. By the end of March 2004 there
were 6,902 people registered on the Central
Treatment List.
New initiatives announced in the 2002 Agreed
Programme for Government, for which progress is
not reported, include:
■ the Garda Working Group tasked with examining
drug prevalence levels and distribution networks
and recommending appropriate resourcing
requirements in light of its findings;
■ the Drug Offenders Bill, which is intended to
provide for registration of convicted drug
dealers with the Gardaí and to provide for stiffer
penalties for persons involved in the supply of
drugs to a prisoner;
■ corporate social responsibility initiatives in
relation to combating drug misuse. (Brigid Pike)
Electronic versions of An Agreed Programme for Government and
the Government Progress Report for 2003 and 2004 are
available on the Department of the Taoiseach website at
www.taoiseach.gov.ie
Sport and the arts should ‘constitute an essential
component of a broader child-centred, multi-tiered
strategy for substance abuse prevention’. This is the
main conclusion of an Oireachtas Committee report
investigating the effectiveness of sport and the arts
as deterrents against substance abuse by young
people under the age of 18 in Ireland.1
Based on a review of national and international
literature, and consultation with a wide range of
interested parties, the Committee concluded that
involvement in sport or the arts facilitates the
holistic development of the person and reduces the
propensity to abuse various substances. 
Sport was found to be associated with enhanced
self-esteem and self-discipline, the prevention of
boredom and the promotion of leadership skills,
empowerment, positive relationships and role
models. Various artistic activities (e.g. music, visual
arts, dance, drama) were found to contribute to
cognitive development, greater self-awareness and
self-confidence, and positive social interactions.
Studies from Australia, the UK and the US were
cited that found a positive link between
engagement in sporting or artistic activities and
reduced levels of involvement in substance abuse.
Exploring current provision of sports and arts
programmes in Ireland, the Committee found that
the formal education sector fails to give proper
recognition to the role of both sport and the arts,
as evidenced by a lack of dedicated time within the
school day, a shortage of adequately trained
teachers, and a lack of facilities. In the non-formal
sector, the Committee found many dynamic and
effective sporting programmes, but reported that
they lacked long-term planning and coherent
policy development, and were chronically under-
funded and under-resourced. The arts area was
even weaker: with youth arts programmes being
provided largely as pilots, the Committee found a
lack of long-term commitment and resourcing, and
poor inter-agency co-operation. 
The Committee made 13 recommendations, which
would see the creation of a ‘multi-tiered’
infrastructure for delivering integrated and co-
ordinated sport and arts programmes for young
people:
■ establishment of a Youth Affairs Ministry and
Department, to maintain policy oversight and
budgetary control in arts, sport and youth
affairs;
■ expansion of the role of statutory bodies, such
as the Arts Council and the Irish Sports Council,
to undertake tasks such as establishing best
practice and ensuring a more integrated
approach by the various organisations involved
in programme provision and delivery; 
■ creation of local arts partnerships (LAPs) and
the extension of local sports partnerships (LSPs),
to co-ordinate the local delivery of sports and
arts programmes;
■ development of a variety of resourcing
mechanisms, including innovative use of
available resources, extending the school day by
30 minutes to provide for physical education
within the school day, and accessing funds from
the private sector and monies from the Dormant
Accounts Fund and the Criminal Assets Bureau;
■ inclusion of alcohol in the National Drugs
Strategy.
Government Progress Report 2004: 
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The report calls for improved integration and co-
ordination of policies and programmes. A
statement on page 13 of the report highlights the
challenge implicit in such aspirations: 
Many young people come from troubled families
and lack respect for the formal education
structures where they are preached to and feel
marginalized. Within the sporting environment,
young people develop respect for their coaches
and mentors. Coaches can then use their
leadership positions to convey a positive non-
[substance] use message to young people and can
become positive role models for all participants.
As well as co-ordinating the practical aspects of
programme delivery, such as timing or resourcing,
to ensure there are not overlaps or gaps in service
provision, it is also necessary to examine the
philosophical assumptions and principles
underpinning various programmes, to ensure they
complement and mutually reinforce one another,
rather than cancel each other out or retard
progress.2 (Brigid Pike)
1. Houses of the Oireachtas. Joint Committee on Arts, Sport,
Tourism, Community, Rural and Gaeltacht Affairs. Fourth
Report. The Effectiveness of Investment in Sport and the Arts
as a Deterrent Against Youth Substance Abuse. April 2004.
2. EMCDDA. Co-Ordination: A Key Element of National and
European Drug Policy. Drugs in Focus, No. 9, May–June
2003, calls for research into the effectiveness of present
mechanisms for drugs co-ordination at both national and
international level as a prerequisite to improvement.
Sport and arts should be part of youth substance abuse
prevention strategy (continued)
Inter-agency protocols – a model of good
practice for agencies working with current
and former drug users in Blanchardstown
drugnet Ireland
On 1 October 1 2004, the Blanchardstown EQUAL
Initiative was launched at Croke Park as a model of
good practice.1 The agencies involved include the
Rehabilitation/Integration Service (RIS) of the
Northern Area Health Board (NAHB),
Blanchardstown Local Employment Service, the
BOND project, Coolmine Therapeutic Community,
Hartstown/Huntstown Community Drug Team,
Mountview/Blakestown Community Drug Team,
Mulhuddart/Corduff Community Drug Team and
the Tolka River Rehabilitation Project. 
The Initiative was developed to establish a co-
ordinated approach to providing quality supports
and services to former and current drug users in
the Blanchardstown area. The agencies involved
expressed the view that clients can ‘fall through the
gaps’ and are often not in a position to assess
appropriate services when required. The key
objective was to bring together statutory and
voluntary agencies working with current and
former drug users in order to establish clear inter-
agency protocols and good working relationships.
The primary aim is to enhance opportunities for the
target group to progress towards employment
opportunities. 
Developments to date include a protocol on lead
agency working, which provides a definition of the
term and establishes the responsibilities of the lead
agency. According to the protocol, a lead agency
assumes the most significant role in providing and
co-ordinating services to a client, including the
provision of a key worker. Responsibilities include
carrying out a needs assessment, holding and
managing the overall care plan and tracking and
following up on a client to prevent a ‘fall through
the cracks’. In addition, a protocol on
confidentiality has been developed and adopted by
all eight participating agencies, covering areas such
as the limits of confidentiality, sharing client
information, working with under-18s and
accommodating clients’ access to files containing
information on them. 
The development of the protocols followed
extensive inter-agency work from mid-2003 to
February 2004 assisted by an independent
facilitator.2 From February to April 2004 the
protocols were piloted among the agencies.
Preliminary evaluation results in Table 1 below
show that co-operation between agencies is
improving, particularly on the challenging issues of
18
Table 1 Indicators of inter-agency co-operation between organisations involved in protocols, 2004
Activity February March April
No. of inter-agency referrals 22 25 26
No. of three-way meetings 0 7 10
No. of lead agency referrals 0 2 4
Total No. of inter-agency activities 22 34 40
Source: Blanchardstown EQUAL Initiative (2004) Making inter-agency protocols work, Appendix 2 (McDonnell).
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three-way meetings and lead agency referrals. A
three-way meeting is one between the lead agency,
the agency the client has agreed to be referred to
and the client. 
The evaluation noted that three-way meetings
were consistently reported as being positive both
for introducing clients to new agencies and for
resolving issues arising for clients between
agencies. The lead agency approach is seen by
most agencies as having clarified the roles of other
services and allowed the interventions to be client-
focused. Following the pilot phase, all eight
agencies agreed to mainstream the use of the
protocols in their work programmes; however, lead
agencies recognise that these new approaches will
take time to develop, to embed and to implement. 
As part of the evaluation of the pilot phase, a
facilitated focus group session was held with eight
clients in early September 2004. All the clients had
been through the inter-agency initiative and found
it to be an improved way of working. According to
the evaluator, they questioned why it was not used
everywhere when it had so many advantages for
service users. 
While this initiative is quite new, its innovative
approach to the process of working with current
and former drug users has been acknowledged. The
National Drugs Strategy 2001–2008 is premised on
the theme of an inter-agency approach across the
100 actions; however, the strategy does not outline
any specific recommendations or guidelines on how
such an approach could be developed. The
Blanchardstown EQUAL Inter-agency Initiative is an
innovative exercise in attempting to work out the
details of inter-agency relationships on the ground.
It is a model with a great deal of learning outcomes
to offer policy makers and service providers
interested in establishing good inter-agency
protocols. Its future development merits close
attention. (Martin Keane)
1. Blanchardstown EQUAL Initiative (2004) Making inter-
agency protocols work: The development of common
protocols by agencies working with current or former drug
users: a model of good practice. Dublin: Blanchardstown
EQUAL Initiative.
2. Rita Burtenshaw of Burtenshaw Kenny Associates.
Dún Laoghaire Rathdown Local Drugs Task Force
(LDTF) developed three community-based projects
in the late 1990s to fill the gap (at that time) in
substance misuse education in local primary
schools: the Whitechurch Addiction Support Project
(WASP), the Parents Making Children Aware
(PMCA) project and the Sallynoggin Parents
Education and Awareness of Drugs Project (SPEAD).
The three projects train local parents as facilitators
to deliver school-based substance misuse education
courses to fourth, fifth and sixth class students.
Course materials include lessons on smoking,
alcohol, drugs, assertiveness, and making choices.
All three projects emphasise a focus on self-esteem.
Projects use active learning methods including
discussion, role-play, group work, games,
worksheets and project work. Courses were
delivered in 16 schools in the period
September–December 2003. 
In 2003 Dún Laoghaire Rathdown LDTF
commissioned a research project to gather
information on the opinions of four key groups in
relation to the value of community-based substance
misuse prevention courses now that primary
schools have available to them the Walk Tall
programme through Social, Personal and Health
Education (SPHE).1 The four key groups were:
children who had received the courses delivered by
the three projects; the parents/guardians of these
children; the facilitators who delivered the courses
(parents); and school personnel (principals and
teachers) involved in the courses.
Information was collected over a four week period
in November and December 2003 from these four
key groups using the following methods:
■ A random sample of 158 children from those
who had finished the courses in the first term of
the current academic year was surveyed by a
questionnaire administered in the classroom
setting. All children responded.
■ Parents/guardians of the children were
surveyed, with all children being given a
questionnaire to bring home to their parents
and to be returned by post. Of the 158 given
out, 62 were returned, giving a response rate of
39 per cent.
■ Questionnaires were sent to facilitators on each
project. Of the 17 sent out, seven were
returned, giving a response rate of 41 per cent.
■ Forty-five questionnaires were sent to school
personnel in the 16 participating schools; 19 were
returned, giving a response rate of 42 per cent.
It should be noted that the response rates for the
latter three key groups were low and thus may not
be representative. Findings relating to two main
questions in the study are shown in Table 1.
Inter-agency protocols (continued)
It is interesting to note that, across the four key
groups, teachers are rated quite low as an option to
teach children about drugs or for children to talk to
about drugs. Only a small percentage of school
personnel themselves believe that children would
find it easy to talk with teachers about drugs.
Responses from school personnel included
comments such as ‘teachers do not have the
expertise on drugs shared by course facilitators’;
reservations were expressed about the priority
given to ‘social subjects’ like drug education.
Although these findings relate to the perceptions
and views of these small groups and have
limitations in terms of generalising to the national
picture, they do raise questions for policy makers
and educational authorities on the exclusive
reliance on teachers to deliver drug education
through the Walk Tall/SPHE programme in primary
schools. Indeed, the position of teachers as
providers of drug education is further challenged
by the children’s high rating of former drug users
as teachers of substance use prevention. This
despite the background that teachers were
delivering the Walk Tall programme in most of the
schools covered in this research, with no evidence
that former drug users were involved in drug
education. 
When children were asked to suggest ways that
schools could prevent children getting involved in
drugs, the most frequent suggestion was:
information accompanied by a video about drugs,
the harm caused by drugs to the person and the
risks of getting addicted to drugs. In addition, the
children reported that what they ‘liked’ most about
the course was the information given about various
types of drug, including alcohol and nicotine. This
would support the view that school-going children
want drug-specific information from credible
sources and see course facilitators and former drug
users among such sources. 
In terms of the usefulness of community-based
drug prevention courses, 37 per cent of parents
regard such courses as ‘very useful’, compared to
15 per cent who view school programmes such as
Walk Tall as being ‘very useful’. In addition, 90 per
cent of school personnel and the majority of course
facilitators reported that SPHE provision in the
schools was greatly enhanced by the local courses.
This demonstrates that three of the key groups
surveyed in this research see a role for community-
based drug prevention courses to complement the
goals of SPHE in primary schools. 
In summary, the positive views of children, parents
and school personnel on community-based drug
prevention in schools would suggest that the
question of mainstreaming this model requires
further exploration by policy makers and
educational authorities. This research demonstrates
that these children want drug-specific information
from their schools; their views and the views of
school personnel raise questions about the capacity
of teachers to deliver such specific information
through the SPHE programme. (Martin Keane)
1. Collins B (2004) Community-based substance misuse
prevention courses in primary schools: a study. Dublin: Dún
Laoghaire Rathdown Local Drugs Task Force.
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This would
support the view
that school-
going children
want drug-
specific
information from
credible sources
and see course
facilitators and
former drug
users among
such sources.
Research questions Children Parents Course facilitators School personnel
First choice
Preferences
First choice
preferences
First choice 
preferences
First choice
preferences
Who do key
groups believe
should teach
children about
substances/
prevention?
Course facilitators
(55%)
Parents (22%)
Former drug user
(20%)
Other (3%)
Parents (62%)
Course facilitators
(20%)
Former drug user
(8%)
Teachers (7%)
Other (3%)
Course facilitators
(43%)
Parents (43%)
Other (14%)
Parents (63%)
Course facilitators
(32%)
Former drug user
(5%)
Who do key
groups believe
children would find
it easy to talk to
about drugs?
Parents (45%)
Course facilitators
(30%)
Friends (17%)
Other (8%)
Parents (50%)
Course facilitators
(22%)
Friends (14%)
Family (7%)
Other (7%)
Course facilitators
(71%)
Friends (29%)
Course facilitators
(57%)
Teachers (16%)
Parents (11%)
Friends (11%)
Former drug user
(5%)
Table 1
drugnet Ireland
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Welcome to the ninth EDDRA (Exchange on Drug
Demand Reduction Action) column. The aim of this
column is to inform people about the EDDRA online
database, which exists to provide information to those
working in the drugs area on current demand reduction
action across Europe, and to promote the role of
evaluation in reducing demand for drugs. The database
is co-ordinated by the European Monitoring Centre for
Drugs and Drug Addiction (EMCDDA). This column will
focus on an Irish project recently added to the EDDRA
database, the Killinarden Drug Primary Prevention
Group. This project is a useful example of good practice
in drug prevention activities in Ireland. 
The Killinarden Drug Primary Prevention Group (KDPPG)
emerged in 1993 as part of a community-led response to
what was perceived as an acute drug misuse problem in
the Killinarden area of Tallaght. The KDPPG highlighted
the lack of drug education programmes for parents and
young people within the community and local schools.
This often meant that young people who were exposed
to drugs lacked proper information on the risks and
consequences of using such drugs. The KDPPG took the
innovative step of training local parents as facilitators to
deliver drug education courses in local schools. The
Group also acted as a support service to local families and
community-based organisations seeking awareness on
drug-related issues or wishing to address drug misuse
within their particular setting. In drug prevention
literature, the work of the KDPPG belongs to the category
of selective prevention. These are interventions targeting
specific at-risk areas and groups and are different from
universal intervention which targets entire populations,
e.g. whole school-going populations.
Currently the KDPPG delivers drug prevention activities
to third, fourth, fifth and sixth class students in three
primary schools in Killinarden. Activities designed to
enhance the self-esteem of third and fourth class
students include a mixture of games, role-play exercises
and quizzes. Students in fifth and sixth classes receive
drug awareness education including information on
different types of drugs and the consequences of use. A
follow-up programme aiming to build on the self-
esteem and drug education activities is delivered in
Killinarden Community School to students up to third
year of secondary school. From 1995 to 2003, an
estimated 800 young people participated in the various
school-based drug prevention activities. 
The work of the KDPPG was evaluated by Rourke (2003)1
using in-depth semi-structured interviews with KDPPG
staff and management, with local parents trained as
facilitators, and with teachers and young people.
Evaluation included a number of on-site observations of
programme delivery in local schools. The evaluation was
process orientated, looking at the project’s
implementation and how it was perceived among target
groups. It also sought to assess the extent of awareness
and understanding of the dangers associated with drug
misuse among young being targeted by the intervention. 
The evaluation findings highlight what can be achieved
when a community is motivated to respond to the
challenge of drug misuse facing local families. The
findings demonstrate that the KDPPG has designed and
implemented a project that is well received by the target
groups and legitimised by local teachers. 
■ Parents trained as facilitators report improved
parenting skills, increased knowledge about drugs
and a perception that their work is making a
valuable contribution to the prevention of drug
misuse in their community. Many parents who were
early school leavers report that the KDPPG was a key
motivating factor in their returning to adult
education. 
■ Teachers report that young people interact with
local parents in a more open and discursive way
than they might relate to teachers or to external
‘experts’. Local parents are seen as having the
credibility to ‘tell it as it is’. Teachers also report that
local parents are professional, efficient, punctual and
well prepared when delivering their presentation.
■ Young people are seen to relate well to the issues
being raised by parent facilitators in the schools, for
example, how young people perceive themselves,
their experience of peer pressure and how to be
assertive when offered drugs. In addition, young
people have become more aware and more
informed about the dangers and consequences of
drug and alcohol misuse and many have become
more assertive and seem less likely to succumb to
peer pressure to use drugs.
The evaluator notes that contact made in schools
between local parents and young people is continued
and built on in the home and through interaction in the
local community. For a high proportion of young people
attending local schools, the consistent involvement with
the KDPPG over a number of years serves to consolidate
the central themes of drug prevention. 
Perhaps the most surprising and interesting finding from
the evaluation is the extent to which young people
engaged with local parents/facilitators in the classroom
setting on such sensitive issues as self-esteem and drug
misuse. This is an important lesson for policy makers,
school authorities and concerned parents to grasp. It
shows that young people can trust and engage with
local parents on sensitive issues providing that those
parents have received appropriate training and are seen
as credible in the classroom. (Martin Keane)
1. Rourke S (2003) Evaluation of Killinarden Drug Primary Prevention
Group. Dublin: KDPPG. 
More information on the Killinarden project and on
other Irish projects on the EDDRA database can be
obtained from the EDDRA website at
http://eddra.emcdda.eu.int
If you have a project that has been evaluated and you
would like to have it highlighted in this column and
included on the EDDRA database, please contact the
EDDRA Manager for Ireland, Martin Keane, Health
Research Board, Holbrook House, Holles Street, Dublin
2. Tel: 01 6761176 Ext. 169; Email: mkeane@hrb.ie 
The EDDRA column
Between June and September 2004, staff at the
DMRD published three occasional papers on
treated drug misuse in the seven health board areas
outside the Eastern Regional Health Authority
(ERHA) area, namely: the Midland, Mid-Western,
North Eastern, North Western, Southern, South
Eastern and Western Health Boards.  The analysis
presented in these papers is based on data
submitted by service providers to the National
Drug Treatment Reporting System (NDTRS).  
Occasional Paper 11: Treatment demand in the
seven health boards areas outside the Eastern
Regional Health Authority, 1998 to 20021
The data presented in Occasional Paper 11 provide
a description of demand for drug treatment
services in seven health boards. This paper will help
inform service planning and provision. 
The main findings and their implications are: 
■ The number of new and previously treated
cases in the seven health boards (outside the
ERHA area) almost trebled between 1998 and
2002. 
■ Both new and previously treated cases in the
seven health board areas most frequently
reported that cannabis was their main problem
drug between 1998 and 2002. The total
number of cases reporting cannabis as their
main problem drug trebled, increasing from
409 in 1998 to 1,359 in 2002. The numbers
treated for problem opiate use almost trebled,
from 184 in 1998 to 532 in 2002. Opiate use
was more common in the health board areas
bordering the ERHA area. Though small, the
numbers treated for cocaine use increased
consistently.  
■ Although there was a small decrease in the
proportion of cases taking more than one drug
(polydrug use), from 84 per cent in 1998 to 77
per cent in 2002, it remained a common
practice and is associated with poorer treatment
outcomes.  Polydrug use is an issue that needs
to be addressed in a client’s treatment plan. 
■ The number of treated cases who reported
injecting more than doubled, from 148 in 1998
to 342 in 2002. Half of the injector cases had
started injecting before they were 20 years old.
Injectors have a higher risk of acquiring blood-
borne viral infections and experiencing
overdose than non-injectors. This suggests that
the drug treatment services outside the ERHA
area require prevention and treatment
interventions to deal with blood-borne viruses
(in particular HIV, hepatitis B, and hepatitis C)
and drug overdose (in particular opiate-related
overdose). 
■ The proportion of treated cases under 18 years
old increased by four per cent over the
reporting period and, as expected, was much
higher for new cases than for those previously
treated. Those under 18 years old require
different approaches to treatment and it is
important that this is recognised in service
planning. 
■ The low levels of educational achievement and
employment among chronic problem drug
users emphasises the importance of close links
between treatment interventions and social and
occupational reintegration programmes.
Occasional Paper 12: Trends in treated problem
drug use in the seven health boards areas outside the
Eastern Regional Health Authority, 1998 to 20022
The data presented in this paper describe trends in
treated problem drug use in seven health board
areas. The total numbers include 7,545 cases who
lived and were treated in the seven health boards
between 1998 and 2002. In this paper, problem
drug use is described in relation to person, place
and time. This paper will assist policy makers,
service planners and public health practitioners to
develop appropriate responses to problem drug use
in the future. 
The main findings and their implications are: 
■ Both the incidence and prevalence of treated
problem drug use almost trebled between 1998
and 2002 (Figure 1). For example, the
incidence of treated problem drug use
increased from 24.8 per 100,000 of the
population in 1998 to 69.7 per 100,000 in
2002. This observed increase may be explained
by a true increase in use, an increase in access
to treatment services, new legislation
encouraging more people into treatment, or an
increase in the number of centres reporting
cases to the NDTRS. The most likely explanation
is a combination of all these factors. 
Updated analysis from the National Drug
Treatment Reporting System
drugnet Ireland
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Figure 1 Incidence and prevalence of treated problem
drug use among persons aged between 15 and 64 years
living and treated in the seven health board areas, based on
returns to the NDTRS per 100,000 population, 1998 to
2002 (Central Statistics Office 2003)
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■ The incidence of treated problem drug use for
the reporting period was highest in the
Southern Health Board area, followed closely by
the South Eastern Health Board area. The
Western Health Board area had the lowest
incidence, indicating lower drug use rates than
in the rest of Ireland, lower access to or uptake
of appropriate treatment services, or lower
levels of participation in the NDTRS. This
requires investigation. 
■ The total number of treated cases reporting
cannabis as their main problem drug trebled,
increasing from 392 in 1998 to 1,328 in 2002.
The numbers treated for problem opiate use
also increased steadily, from 116 in 1998 to 439
in 2002. Opiate use was more common in the
health board areas bordering the ERHA area.
The second most frequently reported main
problem drug was ecstasy for new cases and
opiates for previously treated cases. Though
small, the number of new cases reporting
cocaine use increased from six in 1998 to 42 in
2002. These findings indicate that treatment
services must cater for a wide spectrum of illicit
drugs rather than focus on one or two drugs,
and must be capable of adjusting treatment
approaches in accordance with changing
patterns of problem drug use.
■ Although there was a small percentage decrease
in polydrug use among treated cases, from 84
per cent of cases in 1998 to 79 per cent in
2002, it remained a common practice and is
associated with poorer treatment outcomes. 
■ The number of treated cases who reported
injecting trebled, increasing from 96 in 1998 to
284 in 2002. Injectors have a higher risk of
acquiring blood-borne viral infections and
experiencing overdose than non-injectors. 
■ The proportion of treated cases under 18 years
old increased by just over three per cent during
the reporting period and, as expected, was
much higher for new cases than for those
previously treated. Those under 18 years old
require different approaches to treatment and it
is important that this is a consideration during
service planning. 
■ The main problem drug reported by new cases
was examined by selected socio-demographic
and drug-using characteristics and some
important relationships were identified. Young
teenagers initiated drug use with cannabis and
volatile inhalants. The use of opiates, ecstasy and
amphetamines was commenced in mid to late
teens. There were differences in type of drug used
by males and females, with very high proportions
of males treated for cocaine and cannabis use
compared to their female counterparts. The
highest rates of employment were among those
using drugs commonly associated with social
events, and the lowest rates of employment were
among those who used opiates and
benzodiazepines. This observation (along with the
high rates of early school leaving) has important
implications for the social and occupational
reintegration of opiate and benzodiazepine users.
Occasional Paper 13: Trends in treated problem
opiate use in the seven health board areas outside the
Eastern Regional Health Authority, 1998 to 20023
The data presented in this paper describe trends in
treated problem opiate use in seven health board
areas. The total numbers include the 1,495 opiate
cases who lived and were treated in the seven
health board areas between 1998 and 2002. In this
paper, treated problem opiate use is described in
relation to person, place and time. This paper will
assist policy makers, service planners and
practitioners to develop appropriate responses to
problem opiate use in the seven health board areas. 
The main findings and their implications are: 
■ The incidence of treated problem opiate use
increased sharply, from 2.0 in 1998 to 8.3 in
2002, per 100,000 of the 15–64-year-old
population (Figure 2). This observed increase may
be explained by a true increase in use, an increase
in access to treatment services, new legislation
encouraging more people into treatment, or an
increase in the number of centres reporting cases
to the NDTRS. The most likely explanation is a
combination of all these factors.
■ The prevalence of treated problem opiate use has
also increased steadily, from 6.6 per 100,000 of
the 15–64-year-old population in 1998 to 25.4 in
2002, and this is an indicator that problem heroin
use has a chronic element requiring continued
care or repeated treatment over time. 
■ There was a spread by county in demand for
treatment for problem opiate use among new
cases living in the seven health board areas,
with very high rates of treated problem opiate
use in counties Carlow, Cavan, Louth, Meath,
and Westmeath. These data will be useful when
assessing the adequacy of existing services or
identifying new sites for treatment services. 
Updated analysis from the National Drug Treatment
Reporting System (continued)
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Figure 2 Incidence and prevalence of treatment for an
opiate as a main problem drug among persons living and
treated in the seven health board areas per 100,000 of the
15–64-year-old population (Central Statistics Office 2003),
based on returns to the NDTRS, 1998 to 2002
Update on newly diagnosed HIV infections
■ The lowest rates of treatment for problem
opiate use were along the western seaboard;
this may be partly due to under-reporting. 
■ For new cases reporting problem opiate use,
the time interval between commencing opiate
use and starting treatment remained between
3.5 and 3.8 years from 1999 to 2002. Polydrug-
using practices may be initiated during the
interval between first taking any drug and the
age at which opiate treatment is sought. During
the time interval between commencing opiate
use and seeking treatment, opiate users may
change from smoking to injecting opiates and,
subsequently, may contract blood-borne
viruses, such as hepatitis C, indicating the need
for proactive interventions to discourage the
move from smoking to injecting and bring
opiate users into treatment earlier. 
■ The proportion of opiate cases treated in the
seven health board areas who reported
polydrug use decreased from 80 per cent in
1998 to 74 per cent in 2002. Polydrug use is
one of the factors that may impede successful
treatment for problem opiate use unless specific
interventions are introduced to address this
problem. 
■ For cases treated in the seven health board
areas who reported opiates as their main
problem drug and reported using more than
one drug, the most common secondary drug
used was cannabis. During the period under
review, the use of cocaine and benzodiazepines
as second drugs increased, while the use of
amphetamines as a second drug decreased. An
exact knowledge of polydrug use is very
important for the correct and comprehensive
management of opiate users. 
■ Of note, there was an increase in the actual
number of injectors treated in the seven health
board areas. Opiate injectors have a higher risk
of acquiring blood-borne viral infections and of
experiencing overdose than non-injectors. This
suggests that the incidence of blood-borne viral
infections and opiate-related deaths has
increased in the seven health board areas
during the period under review, but specific
data are not available. 
■ Problem opiate users’ educational characteristics
indicate that individuals who leave school early
are more likely to become problem opiate users,
or that the lifestyle of problem opiate users
renders it difficult to stay in full time education,
or a combination of both factors. In line with
national employment trends, there was an
increase in the proportion of new and previously
treated opiate cases who reported having regular
employment up to 2001 and a subsequent
decrease in 2002. Taken together, these two
findings indicate the importance of a social,
educational and economic reintegration strategy
for the successful treatment of opiate users. 
(Jean Long)
1.  Long J, Kelleher T, Kelly F, Sinclair H  (2004) Treatment
demand in the seven health boards outside the Eastern
Regional Health Authority, 1998 to 2002. Occasional Paper
11. Dublin: Health Research Board.  
2.  Long J, Kelleher T, Kelly F, Sinclair H  (2004) Trends in
treated problem drug use in the seven health boards outside
the Eastern Regional Health Authority, 1998 to 2002.
Occasional Paper 12. Dublin: Health Research Board.  
3.  Long J, Kelleher T, Kelly F, Sinclair H  (2004) Trends in
treated problem opiate use in the seven health boards outside
the Eastern Regional Health Authority, 1998 to 2002.
Occasional Paper 13. Dublin: Health Research Board.  
These papers are available on the Health Research Board
website at www.hrb.ie
The National Disease Surveillance Centre reported
that there were 399 newly diagnosed HIV infections
reported in 2003.1 There were 47 new diagnoses
among injecting drug users during 2003, compared
to 50 in 2002 and 38 in 2001. There was a higher
number of new infections among male injectors
(30, 64%) than among female injectors (17, 36%).
The average age of HIV diagnosis for injecting drug
users was 29 years. Of the 47 newly diagnosed
cases, 45 were born in Ireland and 43 lived in the
Eastern Regional Health Authority area. The
cumulative total of HIV cases reported to the end of
December 2003 was 3,408, of whom 1,131 (33%)
were injecting drug users. (Jean Long)
1.  NDSC (2004) Newly diagnosed HIV infections in Ireland.
Quarter 3 & 4 2003, & 2003 Annual Summary. Dublin:
National Disease Surveillance Centre. 
Updated analysis from the National Drug Treatment
Reporting System (continued)
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The National Documentation Centre on Drug Use
(NDC) is preparing to launch its redesigned
website. The website is being changed to
accommodate a range of new information
resources and to make existing resources more
accessible to visitors. The new site will provide
visitors with:
■ a simplified search option which will allow
them to search the NDC simply by choosing
the subject heading which interests them
■ most recent news stories available on the
website’s home page
■ electronic versions of all articles from back
issues of Drugnet Ireland, which will appear as
they do in the print version of the newsletter
■ information notes on aspects of drug use in
Ireland, including prevalence, legal issues, drugs
policy and infectious diseases
■ table of contents for current issues of NDC
journals
■ an electronic version of the DMRD’s national
report on the drugs situation in Ireland in an
easily accessible and readable format
The NDC is continuing to develop its electronic
library – there are now over 700 full-text
documents available on the website – and its
collection of books, reports and other literature.
NDC users have made extensive use of the library’s
inter-library loan and document delivery services
and over 500 journal articles have been supplied to
users this year. The NDC is also adding several titles
to its journals listing and these will be available to
library visitors from early next year. 
Group visits to NDC
A number of groups have visited the National
Documentation Centre on Drug Use recently to
learn about the resources available and how the
NDC’s information resources can assist them in
their work and study. Among the visiting groups
were the MSc in Drug and Alcohol Policy (TCD)
class, the Diploma in Addiction Studies (TCD) class,
Graduate Diploma in Nursing Addiction and
Substance Related Difficulties (DCU) class and a
delegation from Norway who were on a EURAD
study visit to Dublin to mark Norway’s Action Week
Against Drugs. A number of other visits have been
planned for the winter and NDC staff will also be
making a number of external presentations. If you
are interested in arranging a visit, or a presentation
on the NDC in another location, please contact the
National Documentation Centre on Drug Use at
ndc@hrb.ie.
Current Research and Evaluation Database
The National Documentation Centre is currently
compiling a database of ongoing research and
evaluation in the drugs area in Ireland and a
directory of researchers and evaluators. This
contains details of research interests and projects
which the researcher or evaluator is currently
involved in. 
Online forms, which researchers and evaluators can
use to provide details of their work, are currently
available on the NDC website. These forms are
short, easy to complete, and will allow researchers
and evaluators to create a thorough and
informative record of their work. These information
resources will be available to all website visitors
when the redesign of the site is complete. If you
wish to add your name to the directory, or provide
information on research you are currently working
on, please contact Damien Walshe at
dwalshe@hrb.ie (Brian Galvin)
For further information on these research resources
contact the National Documentation Centre on
Drug Use, Health Research Board, Holbrook House,
Holles Street, Dublin 2. Tel: 01 676 1176; Email:
ndc@hrb.ie or visit the website at www.hrb.ie/ndc
National Documentation Centre on Drug Use
The 2004-06 MSc in Drug and Alcohol Policy (TCD) class 
on a visit to the NDC
A delegation from Norway, with Ms Grainne Kenny, attending a EURAD
study visit to Dublin to mark Norway’s Action Week Against Drugs,
were welcomed to the NDC by Dr Hamish Sinclair of the DMRD
The National Documentation Centre on Drug
Use is funded by the Department of
Community, Rural and Gaeltacht Affairs under
the National Development Plan, 2000–2006.
Social integration efforts, ‘much
needed’ for foreign inmates
Cited from Petra Paula Merino, Drugnet Europe No.
46, April–June 2004
European prison populations today contain an
overrepresentation of social, cultural and ethnic
minorities, many being immigrants from outside
the EU. … Foreign inmates experience difficulties in
accessing general care, legal support and addiction
services, the main barrier being linguistic. This
ultimately jeopardises their chances for social
integration as they are more likely to experience
health and addiction problems and less likely to be
given a chance for parole. Participants at a recent
conference on ‘Prisons, drugs and society in the
enlarged Europe’ [organised by the European and
Central and East European Networks of Drug
Services in Prison] called for comprehensive
interventions to prevent imprisonment and
integrate immigrants into society by facilitating
their access to employment, health and social
services and education. Meanwhile, effective in-
custody measures cited included peer-support
approaches, cultural mediation and repatriation of
inmates to prison units in their home country.
Other urgent measures proposed related to the
prevention of diseases among detainees, especially
HIV, hepatitis B and tuberculosis.
Treatment now more ‘available,
accessible and diverse’
Cited from Drugnet Europe No. 47, July–September
2004
Measuring public expenditure on drug treatment is
an important indicator of governments’
commitment to the drug problem. Preliminary
estimates from an EMCDDA study of drug-related
public expenditure from 1990–2000 suggest that,
in Member States, 70–75% of the drug budget was
spent on law enforcement and around 25–30% on
the health sector, including treatment for drugs and
related diseases. Although data are insufficient to
draw clear-cut conclusions, and more cost analyses
are required for an accurate picture of spending,
preliminary research shows that within the EU, the
average health-related expenditure for problem
drug users is around €2,000 per person per
annum.
ELDD offers easy access to EU drug
legislation
Cited from Cécile Martel, Drugnet Europe No. 47,
July–September 2004
In 1990, the European Community took its first
legislative action in the field of drugs by ratifying
Article 12 of the 1988 United Nations Convention
Against Illicit Traffic in Narcotic Drugs and
Psychotropic Substances. Since then, the EU has
adopted a battery of over 60 directives, regulations,
recommendations and framework decisions
addressing the drug phenomenon, primarily in line
with the Treaties of Maastricht and Amsterdam. The
EMCDDA has now made these texts available in
one easily accessible archive in its European Legal
Database on Drugs (ELDD). … A descriptive
overview of drug legislation at EU level – the
‘European Union profile’ – has also been published.
This is divided into the following sub-sections:
development of legislation; controlled substances;
drug use and possession; trafficking and drug-
related crime; prevention, care and treatment;
precursors; money laundering and confiscation. The
main purpose of the feature is to provide policy-
makers, researchers, journalists and the general
public with an accessible, up-to-date and
comprehensive reference collection of EU drug
legislation.
[The European Legal Database on Drugs is
accessible at http://eldd.emcdda.eu.int/ ]
Drugnet Europe is a newsletter published by the
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA). The newsletter is published
four times a year in Spanish, German, English,
French and Portuguese. An electronic version of
Drugnet Europe is available from the EMCDDA
website at www.emcdda.eu.int
If you would like to receive a hard copy of the
current or future issues of Drugnet Europe, please
contact Mary Dunne, Drug Misuse Research
Division, Health Research Board, Holbrook House,
Holles Street, Dublin 2, Tel: 01 676 1176 Ext. 127;
Email mdunne@hrb.ie
From Drugnet Europe
drugnet Ireland
26
drugnet Ireland
27
‘Towards a comprehensive system for treating
alcohol-related problems’ was the title of the fourth
annual conference held by the Addiction Research
Centre in Trinity College Dublin in September
2004. A panel of speakers addressed various aspects
of alcohol treatment from both a national and an
international perspective.
The first two speakers outlined the effectiveness,
diversities and similarities of alcohol treatment
systems internationally.
■ Dr Thomas Babor, University of Connecticut,
focused on the scientific evidence for strategies
and interventions designed to prevent or
minimise alcohol-related harm, including
treatment services. He summarised the results
of Project MATCH, the largest controlled
treatment evaluation study ever conducted.1
This study looked at the effectiveness of
matched medication-free therapy for individual
clients. At the end of his presentation Dr Babor
discussed the implications for alcohol policy of
research on treatment methods.
■ Dr Harold Klingemann, University of Applied
Sciences, Bern, discussed the diversity and
similarities across alcohol treatment systems. He
firstly defined treatment and examined its
concepts; this was followed by a description of
the International Study of the Development of
Alcohol Treatment Systems (ISDRUTS), which
was carried out between 1984 and 1990 in 16
countries. He ended the presentation by
focusing on the trends in alcohol treatment in
various countries, which include: new financing
schemes, increased monitoring, evidence-based
practice and less focus on illicit drugs. 
The second session focused on the developments
and failures of Irish alcohol treatment systems.
■ Mr Rolande Anderson, Irish College of General
Practitioners, presented a paper entitled
‘Helping Patients with Alcohol Problems’. An in-
depth look at the increase in alcohol
consumption in Ireland and its societal costs
was followed by an examination of the
relationship between the severity of alcohol
problems and the type of interventions needed.
He identified opportunities for recognising
problem alcohol use among attendees at
general practice. Mr Anderson concluded his
presentation by calling for an increase in the
amount of research/resources presently
allocated to alcohol-related problems in Ireland,
particularly at primary care level.
■ Dr Shane Butler, Addiction Research Centre,
Trinity College, began his paper by reviewing
alcohol treatment planning and service delivery
in Ireland over the past 20 years. He continued
by identifying the main factors that explain the
failure to create an integrated, comprehensive
treatment system at local and regional levels in
this country. Finally, he argued that there is a
need to challenge popular perceptions of and
professional intransigence towards alcohol
misuse in Ireland.
The final session of the day focused on alcohol
policy and the prospects for change.
■ Dr Betsy Thom, Middlesex University, provided
an overview of trends in the development of
alcohol treatment policy in England since 1950.
She outlined ways in which treatment policy
has changed and the factors that have
prompted change or resulted in stagnation.
■ In the final paper of the day, Barry Cullen,
Addiction Research Centre, Trinity College,
explored the need to re-orient the Irish alcohol
treatment system towards a public health model.
He argued that there is a need to develop more
research into alcohol misuse; it is also necessary,
he claimed, to acknowledge and learn from the
failures in the current system and to listen to the
demands for change from the public and from
professionals working in the area. He concluded
by outlining prospects for change, which
include: the need for major investment, the need
to consider an integrated drug and alcohol
approach, and the need for substantial
organisational change at all levels within health
and social care systems. (Fionnola Kelly) 
1.  For more detailed information on Project MATCH, see
Babor T and Del Boca FK (2003) Treatment matching in
alcoholism. Cambridge: Cambridge University Press
Addiction Research Centre Annual Conference
Books
Binge drinking and youth culture:
alternative perspectives
MacLachlan M and Smyth C (eds) The Liffey Press
2004
ISBN 1 904148 42 5
The contributors to this book do not align
themselves with a single definition of the term
‘binge drinking’; rather, they emphasise the
negative consequences that arise from the pattern
of drinking in the context of youth culture. The
book examines the relationship between binge
drinking and the factors that impact on it, and
offers a selection of snapshots from perspectives
that the editors feel have not been sufficiently
developed to date.  It reviews the influence of
advertising, the consumption of pleasure, the use of
education strategies, the physiological effects of
drinking in moderation and to excess, as well as the
response of society to the problem.  
The first section, Literature Review, considers the
causes, consequences and possible ‘cures’ for binge
drinking from a psychosocial perspective. The
second section, Differing Perspectives, considers
arguments that, on the one hand, alcohol in
moderation confers health benefits, while on the
other, excessive alcohol consumption may facilitate
a path to suicide. This section contains a chapter
exploring the connections between alcohol, culture
and suicide in Ireland. The next section,
Contextualising Consumption, provides both
quantitative and qualitative analysis of the
relationship between youth culture and alcohol
consumption, specifically in the Irish social,
economic and cultural context. The final section,
Debates, highlights some of the issues raised in an
open forum discussion with a range of contributors.
Alcohol: no ordinary commodity – research
and public policy
Babor T et al. Oxford University Press 2003
ISBN 0 19 263261 2
From a public health perspective, alcohol is no
ordinary consumer product. On a global level, it is
a major contributor to disease, disability, and
premature mortality. It also has an adverse impact
on many aspects of social life. Alcohol: no ordinary
commodity describes recent advances in alcohol
research that have direct relevance to the
development of effective alcohol policies at the
local, national and international levels. It covers the
search for policies that protect health, prevent
disability, and address the social problems
associated with the misuse of alcohol. The book is,
at its core, a scientific treatise on what alcohol
policy is, why it is needed, which interventions are
effective, how policy is made, and how scientific
evidence can inform the policy-making process.
The book opens with an introduction to the alcohol
policy agenda. The second section presents a
snapshot of drinking patterns and alcohol-related
problems throughout the world, providing a global
panorama of the challenges faced. The third section
critically reviews the evidence for six strategies that
have often been used as a basis for alcohol policy:
taxation and pricing, regulating the physical
availability of alcohol, modifying the drinking
context, measures against drink-driving, regulating
alcohol promotion, education and persuasion
programmes, and treatment and early intervention
services. Section four provides an international
analysis of the policy-making process. The book
concludes with a consumer’s guide to effective
alcohol policy, synthesising what is known about
how communities and nation states can effectively
manage this extraordinary commodity. 
Cocaine
Streatfeild D Virgin Books Ltd 2002
ISBN 0 7535 0627 0
This book presents a definitive history and overview
of cocaine in all its manifestations – from its first
medicinal uses thousands of years ago to the
worldwide chaos it causes today.  Over a two-year
period, the author’s research took him from the
British Library to the jungles of Bolivia and
Colombia.  He interviewed cocaine users and
dealers in many places, including the crack houses
of New York and America’s secure prisons. He talked
to experts and to those involved with the cocaine
trade, from both sides of the law and sometimes in
dangerous circumstances: economists, scientists,
botanists, lawmen, historians and traffickers.     
The cocaine story is presented in three parts,
beginning with the discovery of the stimulant
properties of the coca plant Erythroxylum coca by
pre-Incan tribes in Peru. Streatfeild describes the
plant and the various processes involved in
preparing the leaves for chewing, and in making
medicinal compounds, such as have been used in
South American for millennia.  He goes on to
explain how the coca leaf became cocaine and was
embraced in the 1880s by the medical profession
(particularly Sigmund Freud) for use mainly as an
anaesthetic. He describes early attempts to discover
how cocaine affects the brain and the gradual
realisation of its addictive effects, leading to
attempts to control it by legislation. Further
chapters describe how the cocaine problem grew
from the early twentieth century, and explore its
links with crime and racism. The second part of the
book chronicles the historical background of the
cocaine ‘explosion’, the rise of drug barons, and
the evolution of crack. The author’s findings and
experiences in Mexico, Bolivia, Peru and Colombia
are related in separate chapters in the final section.  
Recent publications
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Journal articles
The following are summaries of a selection of
articles relating to the drugs situation in Ireland
recently published in international journals.
Cocaine use in Europe – a multi-centre study
Haasen C, Prinzleve M, Zurhold H, Rehm J,
Güttinger F, Fischer G, Jagsch R, Olsson B, Ekendahl
M, Verster A, Camposeragna A, Pezous A-M,
Gossop M, Manning V, Cox G, Ryder N, Gerevich J,
Bacskai E, Casas M, Matali JL and Krausz M
European Addiction Research 2004; 10(4): 139–146 
An increase in the use of cocaine and crack in
several parts of Europe has raised the question
whether this trend is similar to that in the USA in
the 1980s. However, research in the field of cocaine
use in Europe has been only sporadic. Therefore, a
European multi-centre and multi-modal project was
designed to study specific aspects of cocaine and
crack use in Europe, in order to develop guidelines
for public health strategies. Data on prevalence
rates were analysed for the general population and
for specific subgroups. Despite large differences
between countries in the prevalence of cocaine use
in the general population, most countries show an
increase in the last few years. The highest rate, with
a lifetime prevalence of 5.2 per cent, was found for
the United Kingdom, although with a plateau effect
around the year 2000. With regard to specific
subgroups, three groups seem to show a higher
prevalence than the general population: (1) youth,
especially in the party scene; (2) socially
marginalised groups, such as the homeless and
prostitutes or those found in open drug scenes; (3)
opiate-dependent patients in maintenance
treatment who additionally use cocaine. Specific
strategies need to be developed to address
problematic cocaine use in these subgroups.
Cocaine use in Europe – a multi-centre study:
patterns of use in different groups
Prinzleve M, Haasen C, Zurhold  H,   Matali JL,
Bruguera E, Gerevich J, Bácskai E,  Ryder, N Butler
S, Manning V,  Gossop M,  Pezous A-Mm, Verster A,
Camposeragna A,  Andersson P,  Olsson B,
Primorac A,  Fischer G,  Güttinger F,  Rehm J and
Krausz M 
European Addiction Research 2004; 10(4): 147–155
The study investigates patterns of cocaine powder
and crack cocaine use in different groups in nine
European cities. A multi-centre cross-sectional study
was conducted in Barcelona, Budapest, Dublin,
Hamburg, London, Paris, Rome, Vienna, and
Zurich. Data were collected by structured face-to-
face interviews. The sample comprises 1,855
cocaine users out of three subgroups: 632 cocaine
users in addiction treatment, mainly maintenance
treatment; 615 socially marginalised cocaine users
not in treatment; and 608 socially integrated
cocaine users not in treatment. Measurements: Use
of cocaine powder, crack cocaine and other
substances in the last 30 days, routes of
administration, and lifetime use of cocaine powder
and crack cocaine. The marginalised group showed
the highest intensity of cocaine use, of heroin use
and of multiple substance use. Of the integrated
group, 95 per cent snorted cocaine powder, while
in the two other groups, injecting was quite
prevalent, but with huge differences between the
cities. Ninety-six per cent of all participants had
used at least one other substance in addition to
cocaine in the last 30 days. The use of cocaine
powder and crack cocaine varies widely between
different groups and between cities. Nonetheless,
multiple substance use is the predominating
pattern of cocaine use, and the different routes of
administration have to be taken into account.
The burden of alcohol misuse on emergency
in-patient hospital admissions among
residents from a health board region in
Ireland
O’Farrell A, Allwright S, Downey J, Bedford D and
Howell F
Addiction 2004; 99(10): 1279
The aim of this study was to identify in-patient
emergency admissions to acute hospitals of
residents from a health board region in Ireland with
an acute alcohol intoxication diagnosis; to profile
the admissions and to assess whether the increase
in alcohol consumption in Ireland has been
mirrored by an increase in alcohol-related
emergency admissions over the same time period.
There were 3,289 acute alcohol intoxication
admissions to acute hospitals of residents from the
study region recorded for years 1997–2001
inclusive. There were 777 acute alcohol intoxication
admissions in 2001, compared to 432 admissions in
1997, an increase of 80 per cent. This study shows
that alcohol intoxication accounted for a substantial
number of emergency in-patient admissions to
acute hospitals in one health board region in
Ireland and that the age-standardised recorded
acute alcohol-related emergency admission rate
increased significantly over the five-year period.
This increase mirrored the national increase in
alcohol consumption over the same time period.
Addressing violence in methadone
maintenance treatment
Quigley P
Heroin Addiction & Related Clinical Problems 2004;
6(1): 5–18
Violence is a core public health issue that is linked
to substance misuse in complex and interactive
ways. Qualitative data on 220 violent episodes were
collected over a three-year period from service
users and staff at Dublin methadone clinics.
Recent publications (continued)
Inductive analysis of the data led to a typology of
violent events, which may help to inform clinical
and social responses to the problem. Witnessed
clinic episodes were interpreted as consequences of
disturbed individual states or traits, or in terms of
immediate situational conflict. Client narratives
were construed as illustrations of family violence,
local feuds, delinquency, dealing, retribution and
abuse. A variety of pertinent clinical and
organisational solutions are put forward in the
context of a necessary community development
and social inclusion process.
Methylenedioxymethamphetamine (MDMA,
‘Ecstasy’): a stressor on the immune system
Connor TJ
Immunology 2004; 111(4): 357–67 
Drug abuse is a global problem impacting on
health. One such health concern stems from the
fact that many drugs of abuse have
immunosuppressive actions and consequently have
the potential to increase susceptibility to infectious
disease. This article is focused on the impact of the
amphetamine derivative,
methylenedioxymethamphetamine (MDMA;
‘Ecstasy’) on immunity. Research conducted over
the last five years, in both laboratory animals and
humans, has demonstrated that MDMA has
immunosuppressive actions. As many of the
physiological changes elicited by MDMA closely
resemble those induced by acute stress, it is
suggested that exposure to MDMA could be
regarded as a ‘chemical stressor’ on the immune
system. Finally, the potential of MDMA-induced
immunosuppression to translate into significant
health risks for abusers of the drug will be
discussed.
Imaging features of soft-tissue infections
and other complications in drug users after
direct subcutaneous injection (“skin
popping”)
Johnston C and Keogan MT
American Journal of Roentgenology 2004; 182(5):
1195–202 
Drug abuse is a serious problem, both globally and
at a local level, with more than 13,400 opiate
abusers in Dublin, Ireland, alone. Infectious
complications are responsible for 60–80 per cent of
hospital admissions of IV drug users. In 2000, in the
United Kingdom and Ireland, fatalities associated
with soft-tissue inflammation and severe systemic
sepsis were linked to ‘skin popping’ (injection of
drugs into the skin and subcutaneous tissues rather
than directly into a vein). Clostridium species were
implicated in the pathogenesis. Superficial infection
may progress to more widespread local or distant
disease. Primary soft-tissue infections in IV drug
users include cellulitis, abscess, myositis,
pyomyositis, and necrotizing fasciitis. Secondary
effects of IV drug use include septic arthritis and
tenosynovitis, secondary osteomyelitis, vascular
complications, soft-tissue ulceration, and fistula
formation. In this review, the range of
complications caused by skin popping that may
develop will be shown. Early imaging to define
disease extent and complications is important
because clinical deterioration can be precipitous. 
Ireland and its drink problem: the
immediate adverse effects of binge drinking
in Ireland 
O’Farrell A
Irish Medical Journal 2004; 97(6): 165-166
This editorial reviews recent research relating to
drink patterns and consequences of binge drinking,
including studies in Ireland. Studies on alcohol-
related hospital attendances and hospital
admissions, alcohol-related road traffic accidents,
suicides, violent assault, sexual violence and rape.
The author concludes that many of the acute
problems related to alcohol arise due to the adverse
effect of the unhealthy binge drinking pattern in
Ireland.
(Joan Moore, Louise Farragher)
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November 2004
2 November 2004
Seminar: Drugs – Mood,
Memory and Mayhem
Speaker: Dr Desmond Corrigan
Venue: Drug Treatment Centre
Board, Trinity Court, 30–31
Pearse Street, Dublin 2. 
Seminar Price: €30.00 per
Seminar or €120.00 per Series (5
for the price of 4) 
All places must be pre-registered,
full details available from: 
Tel: 01 648 8600 Fax: 01 648
8700 
E-Mail: seminars@dtcb.ie 
www.addictionireland.ie
Information: Dr Desmond
Corrigan is a senior lecturer in
the School of Pharmacy, Trinity
College Dublin, Chairperson of
the National Advisory Committee
on Drugs and Chairperson of
Dun Laoghaire–Rathdown Local
Drugs Task Force 1997–2000. He
is the author of Facts about Drug
Misuse in Ireland, now in its 4th
edition.
4–5 November 
2e Congrès de Médecine en
Milieu Pénitentiaire / The
2nd European Congress of
Prison Medicine
Venue: Palais des Congrès,
Strasbourg
Organised by / Contact:
EVENYS Caroline Chaussat ou
Flore Labouret, 17, rue de Seine -
92100 Boulogne 
www.congres-
ucsa.com/english/default.htm 
11–14 November 2004
Fifth Annual National Harm
Reduction Conference 
Venue: New Orleans 
Organised by / Contact:
Paula Santiago
Tel: 001 212 213-6376 ext 15
Email:
santiago@harmreduction.org 
www.harmreduction.org/conf200
4/index.html
Information: Theme of
conference ‘Working Under Fire:
Drug User Health and Justice
2004’. Participants will share
their experiences, as well as
discuss solutions to common
concerns and issues, such as
housing, medical care, the
impact of drug use on families,
the need for needle-exchange
programs and new developments
in the political and criminal
justice arenas. 
18–19 November 2004
From Information to
Response – The role of
qualitative research in
designing strategies to
prevent drug use
Venue: Folkets Hus, Malmö,
Sweden
Organised by / Contact: Ms
Marie Pertoft, Nymans & Schulz
Tel:  46 (8) 429 23 32.
Email: meeting@nymans.se
www.mobilisera.nu/templates/Ge
neralPage____3501.asp
For questions regarding the
programme, please contact Philip
Lalander, SoRAD
Email: philip.lalander@hik.se 
Information: The conference is
being organised by The Swedish
National Drug Policy Coordinator
and the EMCDDA. The main
objective of the conference is to
make better use of qualitative
methods as tools to get closer to
changing trends and attitudes
among young people in order to
inform policies and prevention
interventions and build on what
is really going on in the minds
and social worlds of young
people. Related to this is the
need to access information about
changes in drug use before these
changes cause too much
damage. Keynote speakers will
introduce the main themes,
which will be elaborated in
workshops with presentations
from different European
countries. EU national drug
policy co-ordinators will draw
conclusions on the practical
value of the knowledge
presented at the conference. The
conference targets European
policy makers in the drugs field,
professionals and researchers.
The programme includes plenary
presentations and workshops by
researchers and prevention
professionals.
February 2005
21–22 February 2005 
National Drug Treatment
Conference 
Venue: Victoria Park Plaza Hotel,
London
Organised by / Contact:
Exchange Conference in
association with The Alliance or
contact Monique at Exchange
Conferences 
Tel +44 (0) 20 7928 9152
Email:
moniquetomlinson@wdi.co.uk
www.exchangesupplies.org
Information: A two-day annual
conference addressing all aspects
of drug treatment.  The
conference will include
presentations on:
■ The impact of stimulant,
benzodiazepine and other
non-opioid drug use on
opiate maintenance
treatment
■ Amphetamines: use,
problems and responses
■ Regulation of practitioners –
achieving a balance
■ Magic bullets? Frameworks
for evaluating new
treatments
■ ‘Geriaddicts’: aging and
dependence
■ Models of counselling: are
they all the same?
and will debate the motion: ‘This
house believes we need more
compulsory drug treatment and
testing services’ 
Upcoming events – a selection
March 2005
20–24 March 2005
16th International
Conference on the Reduction
of Drug Related Harm
Venue: Waterfront Hall, Belfast.
Organised by / Contact:
Nicola Johnston, Project Planning
International Montalto Estate,
Spa Road, Ballynahinch,
Co.Down, Northern Ireland BT24
8PT.
Tel: 02897 561993
Fax: 02897 565073
Email: nicola@project-
planning.com
www.ihrcbelfast.com 
Information: A range of broad,
over-arching themes will provide
the focus for the 16th
International Conference on the
Reduction of Drug Related Harm.
The broad themes include:
■ drugs and drug use in
conflict and post-conflict
situations 
■ alcohol and tobacco and
harm reduction
■ criminal justice and harm
reduction 
■ harm reduction and young
people
■ HIV/AIDS and drugs,
including prevention,
treatment and care
■ harm reduction – dimensions
and principles
■ drug laws – the international
perspective
The conference is being
organised by the Department of
Health, Social Services and Public
Safety (DHSSPS) for Northern
Ireland, in association with the
International Harm Reduction
Association (IHRA).The
conference programme is
currently being developed and
will include sessions on alcohol
and tobacco, as well as ensuring
that the issues which typically
form the core of IHRA
conferences will continue to be
addressed and debated. The
organisers are also keen to
ensure that the conference
continues to appeal to those with
a long history of working in the
harm reduction field, as well as
to those for whom it is a
relatively new phenomenon.
Upcoming events – a selection (continued)
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